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ABSTRACT 
Polymorphic epithelial mucins are large complex glycoproteins which consist of a 
single polypeptide backbone, a large domain of which is usually made up of degenerate 
tandem repeats. One such molecule MUC 1 is expressed at the surface of human 
mammary cells and is developmentally regulated and aberrantly expressed in tumours. 
These mucins have been identified as the target antigens for a number of murine 
monoclonal antibodies raised against a variety of immunogens including human milk 
products and breast tumour extracts. The anti-MUC 1 antibodies have been shown to 
display tumour reactivity and have been used both as agents for imaging and in 
immunoassays to assess tumour burden and response to therapy. A number of these 
antibodies have been found to define epitopes within the tandem repeat of the protein 
core of the MUC 1. 
Hydropathicity calculations and secondary structure predictions on the twenty 
amino acid tandem repeat of the MUC 1 core protein have identified a hydrophilic 
domain Pro-Asp-Thr-Arg-Pro-Ala-Pro, which has a high probability of turn formation. 
It is within this domain that the epitopes of the anti-MUC 1 antibodies are found. High 
field n.m.r. studies undertaken on an antigenic twenty amino acid peptide 
corresponding to the tandem repeat sequence of MUC 1 in dimethyl sulphoxide have 
identified the presence of a type-I l3-turn in the region Pro-Asp-Thr-Arg. This turn 
overlaps the epitopes of all of the MUC 1 antibodies characterised to date. 
In an attempt to identify more precisely the conformational requirements for 
binding to two anti-MUC 1 antibodies, HMFG 1 and HMFG2, the solution structures of 
several MUC 1 core related peptides in dimethyl sulphoxide have been investigated. 
All of the peptides studied have been found to contain either l3-turns or modified turns 
which overlap their hydrophilic epitope domains. While these observations may 
provide some explanation for the observed reactivity of the different peptides, they 
give little insight into the precise structural requirements for antibody binding. Due to 
VI 
the flexibility of linear peptides in solution it is not possible to define the side chain 
conformations which are crucial to the processes of antibody recognition. 
In order to define the bound conformations of antigenic peptides using n.m.f., it 
is necessary to undertake experiments in the presence of antibody. Initial experiments 
have been performed in order to determine the conformation of the MUC 1 core 
related twenty amino acid peptide when bound to the anti-mucin antibody C595. In 
addition DNA coding for the variable domains of C595 has been cloned and sequenced 
in order to facilitate both expression of recombinant antibody binding fragments and 
the modelling of the binding site. These studies should provide a clearer understanding 
of the structural basis of antibody recognition of the peptides, and may give an insight 
into the specificity of anti-MUC 1 antibodies for malignant cells. 
vii 
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CHAPTER ONE 
ANTIBODY-ANTIGEN INTERACTIONS 
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1.1 Basic Definitions 
Antibodies, or immunoglobulins, are a group of glycoproteins which are 
present in the serum and tissue fluids of higher animals. Their production is induced 
when the host's lymphoid system comes into contact with immunogenic foreign 
substances. Antibodies have a bi-functional role in the immune system. One part is 
responsible for recognition and binding of infectious agents, while the second activates 
responses which cause their neutralisation. Antibodies have a specific affinity for the 
foreign substance that elicited their production. 
Antigens are foreign macromolecules capable of inducing antibody formation. 
The specificity of an antibody is directed against a particular site on the antigen called 
the antigenic determinant or epitope. In the following discussion only protein and 
peptide antigens will be considered, as the vast majority of structural data available 
describes antibodies complexed to these materials. 
1.2 Antibody Classification 
The basic structure of all immunoglobulins is a unit consisting of two identical 
pairs of polypeptides termed the heavy- (H) and the light- (L) chains. The chains are 
linked by disulphide bridges to form a Y -shaped molecule (Figure 1.1). Antibodies are 
divided into five classes on the basis of the type of H-chain and the number of Y-
shaped units they contain (Table 1.1), namely IgG, IgM, IgA, IgD and 19E. These 
differ from one another in size, charge, amino acid composition and glycosylation. In 
addition to the five types of H-chain, there are two classes of light chain I( and A. 
There are no restrictions on which types of H- and L-chains can form antibodies, 
however any given immunoglobulin molecule will contain only one type ofH-chain and 
one type of L-chain. 
Within a class of antibodies there may also be slight differences in the H-chain 
sequence which give rise to subclasses. Thus, the murine IgG class of molecules 
contains four subclasses: IgG 1, IgG2a, IgG2b and, IgG3. Differences between the 
J 
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subclasses within a gIven immunoglobulin class are less pronounced than the 
differences between the various classes. 
Figure 1.1 
H-chain 
Basic structure of the "Y -shaped" antibody subunit. The bold lines 
represent interchain disulphide bridges. 
1.3 Antibody Structure 
The discussion below focuses on IgG antibodies, which contain only one 
structural Y -shaped unit, and are the most abundant in nonnal serum, however, the 
important structural features of IgG molecules are also present in the Y -shaped units of 
the other antibody classes. In immunoglobulins belonging to the IgG class, the H-
chain contains approximately 440 amino acid residues and has a molecular weight 
around 50,000. L-chains are approximately 220 residues in length and have a 
molecular weight of around 25,000. The whole antibody molecule therefore has a 
molecular weight of 150,000. 
IgG antibodies can be split by the protease papain into three components 
(Porter, 1959 ~ ~ Figure 1.2). Two of these are identical and combine with antigen to 
fonn a stable complex. These are called Fab (fragment antigen binding). The third 
component does not combine with antigen, but can be obtained in a crystalline fonn, 
2 
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and is termed the Fc (fragment crystallisable). The region between the Fab and the Fe 
is called the hinge. This segment allows lateral and rotational movement of the Fab 
arms to facilitate antigen binding. 
Table 1.1 Classes of antibody. 
Class IgG IgM IgA IgD 19E 
Heavy Chain 'Y J.L a 0 £ 
Light Chain Kor A KorA Kor A Kor A Kor A 
Molecular 'Y2K2 or (J.L2K2h or (a2K2}n or ~ K 2 2 or £2K2 or 
Formula 'Y2A2 (J.L2 K2)S (a2A2)n * ~ A 2 2 £2A2 
Structure y ).....Y--Z Y Y Y 
-()-- >--< 
y 
yy 
* n = 1,2 or 3 
Within the antibody molecule there are intrachain disulphide bonds which form 
loops in the polypeptide chain. These loops fold to form separate domains which 
contain approximately 110 amino acid residues (Edelman, 1970 ~ ~ Figure 1.3). L-chains 
contain two domains. The N-terminal domain (V L> shows considerable sequence 
variation from antibody to antibody, while the C-terminal domain (CL> is constant in 
chains of the same type. Sequence variations within the C L domain account for the 
differences between K and A L-chains. H-chains are made up of a variable domain at 
the N-terminus (VH), and three constant domains (CH 1, CH2 and CH3). Within a class 
3 
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of antibody there IS considerable sequence homology between the three constant 
domains. 
Within the variable domains of antibodies there are certain sequences having 
very diverse amino acid sequences (Wu & Kabat, 1970). These regions display 
variability both in sequence and in the number of amino acid residues they contain. 
Figure 1.2 
papain 
cleavage 
site 
Proteolysis of IgG by papain. 
Fab fragments 
-
Fc fragment 
Early crystallographic studies of complexes between antibodies and their 
ligands revealed that these segments come together to produce a continuous 
hypervariable surface which forms the combining site of the antibody molecule (Arnzel 
et ai, 1974 ; Padlan et ai, 1976 ; Arnzel & Poljak, 1979). It has long been thought that 
the specificity of antibody-antigen interactions resides in complementary structures 
being present on the two molecules (Ehrlich, 1900). Consequently, these 
hypervariable domains are referred to as the complementarity determining regions 
(CDRs). The smallest fragment of the antibody which retains its binding capacity for 
antigen consists ofa heterodimer of the VH and VL domains and is called Fv (fragment 
variable). 
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1.4 Monoclonal Antibodies 
Normal serum contains many different types of antibodies that are specific for a 
wide spectrum of antigens. The use of such a mixed population of immunoglobulins 
makes it difficult to obtain reproducible sera, and to define antibody specificities. 
In 1975, Kohler and Milstein developed a method for immortalising a single 
antibody secreting B-cell by fusing it to a myeloma cell (a type of B-cell tumour). 
These hybrid cells (hybridomas), unlike normal plasma cells, can be maintained 
indefinitely ill vitro, and secrete a single type of antibody with a defined specificity. 
The development of hybridoma technology has made it possible to produce 
unlimited numbers of monoclonal antibodies of known specificity against any given 
antigen. This has led to an upsurge of interest in obtaining detailed structural 
information concerning antibody-antigen recognition. 
1.S Antibody-Antigen Binding 
The binding of an antigen to an antibody takes place by the formation of 
multiple non-covalent bonds between the antigen and amino acids of the binding site. 
The attractive forces (hydrogen bonds, electrostatic, van der Waals and hydrophobic) 
involved in these interactions are weak in comparison with covalent bonds. The 
binding affinity of an antibody for its antigen relies on there being sufficient 
complementarity between the binding site and the epitope for multiple interactions to 
occur. 
Non-covalent bonds are critically dependent on the distance (d) between the 
interacting groups. The force is proportional to l/d2 for electrostatic interactions, and 
to I/d7 for van der Waals forces. Thus the interacting groups must be close in 
molecular terms before these forces become significant. In order to overcome 
thermodynamic disruption of the interactions, several non-covalent bonds must form 
almost simultaneously. Consequently the antigenic determinant and the combining site 
must have highly complementary structures for binding to occur. 
5 
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Figure 1.3 Domain structure of IgG antibodies. Disulphide bridges are indicated 
by bold lines. C and N indicate the C- and N-termini of the polypeptide 
chains. 
6 
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1.6 Structural Studies 
A fundamental step in characterising the structural basis of antibody-antigen 
interactions is the identification of the antigenic determinant of the protein. The 
observation that certain antibodies induced by a native protein do not react with the 
denatured form whereas others raised against peptide fragments of the primary 
sequence cross react with the intact protein led to the definition of two classes of 
antigenic determinant (Atassi, 1975). Sequential or linear epitopes consist entirely of 
residues which are local in the polypeptide sequence, while conformational or 
assembled epitopes are composed of residues, distant in the sequence, which are 
brought together by folding of the protein. It is thought that around 90010 of proteins 
contain conformational epitopes (Atassi et aI, 1978 ; Barlow et aI, 1986). A number 
of predictive methods are now available which attempt to identify epitopes from 
certain features of the primary structure of the protein. Parameters such as 
hydrophilicity (Hopp & Woods, 1981 ; K yte & Doolittle, 1982), flexibility (Karplus & 
Schultz, 1985) or a combination of these (Jamieson & Wolf, 1988) have been used. 
None of these predictive algorithms attempt to correlate the antigenicity with the three 
dimensional structure of the protein, and possibly for this reason, they have not been 
greatly successful (Pellequer et aI, 1991). 
In cases where the antibody recognises a sequential epitope it is possible to 
define the antigenic determinant using solid phase peptide synthesis techniques (Geysen 
et aI, 1987). This is achieved by producing a set of overlapping peptides of a given 
length which are homologous with the sequence of the antigen. Antibodies can be 
tested for their ability to bind the peptides using standard immunological methods. 
This approach has been used to identify a number of sequential epitopes (Geysen et aI, 
1987 ; O'Sullivan 1990 ; Xing et aI, 1990, 1991), which have been shown to consist of 
between 3-8 residues. 
Having identified the location and boundaries of the epitope, it is possible to 
further probe the contribution of the individual residues in the epitope to the overall 
binding. This is done by producing a set of peptides, based on the defined epitope, 'in 
7 
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which each residue in tum is systematically replaced by all of the other 19 naturally 
occurring amino acids (Geysen el ai, 1987). If the antibody binding ability of the 
peptide is lost when the original residue is replaced by amino acids of similar character, 
then this residue is thought to contribute directly to the interaction. When the binding 
ability of the peptide is essentially independent of the particular residue present in a 
certain position, it is assumed that the side chain of this amino acid is not in direct 
contact with the paratope of the antibody. Such replacement analysis has been 
successfully applied to determine the fine specificity of a number of MAbs which define 
sequential epitopes on a breast carcinoma associated mucin (Briggs et 01, 1991 ; Xing 
et ai, 1991). 
The problem of defining conformational epitopes is more complex. Early 
attempts to identify conformational determinants relied on enzymic hydrolysis of the 
protein to identify successively smaller fragments which retained binding activity . 
. Crumpton & Williamson (1965) localised some of the antigenic sites on myoglobin by 
obtaining proteolytic fragments which could inhibit antibody binding to the native 
protein. More recently, site directed mutagenesis has been used to define residues 
which are critical for antibody binding. Smith-Gill el al (1982) found that replacement 
of Ar{>8 by lysine in hen egg-white lysosyme led to a IOOO-fold reduction in binding to 
the anti-lysosyme antibody HyHEL-5. However, these methods are extremely time 
consuming, and it is not always apparent whether the loss of binding activity results 
from the substitution of a residue which is essential for antibody recognition, or if the 
substitution causes a major change in the structure of the antigen. 
1.7 X-ray CrystaUography 
Recently, a number of crystal structures of Fab fragments bound to protein 
antigens have been solved (reviewed in Davies et ai, 1990). These provide a direct 
method for identifying those residues on both antibody and antigen which are involved 
in binding, and hence allow precise determination of the antigenic determinant. In 
addition they provide information regarding the degree of complementarity in the 
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complex, and in cases where structural data is available for the free antigen, address 
the question of to what extent conformational changes in the binding region contribute 
to the interaction. 
Of the high resolution structures currently determined, three involve complexes 
with Iysosyme (Amit et ai, 1986 ; Sheriff et ai, 1987 ; Padlan el ai, 1989), and two 
with influenza virus neuraminidase (Colman el ai, 1987 ; Tulip et ai, 1989). In the 
case of lysosyme, a high resolution crystal structure of the free protein is also available 
(Ramandhan et ai, 1989). 
The Fabs in the three anti-Iysosyme complexes describe epitopes that are 
almost entirely non-overlapping, which together cover nearly half of the surface area of 
the protein. Therefore it appears that any part of the protein surface which is 
accessible is potentially antigenic. In all three structures the interface at the combining 
site covers an area of around 750A2, which is sufficient to accommodate 
approximately 15-18 residues from the antigen, and the epitopes defined by the 
antibodies are discontinuous. In the crystal structure of the HyHEL-5 complex 
(Sheriff el ai, 1987), the Art'8 residue was contained in the epitope and was found to 
interact with four of the six CDRs. In the Fab-Iysosyme complexes studied to date, 
there appears to be no major conformational change in either the antibody combining 
site or the backbone atoms of the antigen on binding. However, larger changes have 
been observed for side chains, sometimes involving rotations of aromatic ring systems 
(Padlan et ai, 1989), presumably corresponding to an induced fit of the two species. 
The Fab-neuraminidase complexes form a slightly larger interface than those 
observed with lysosyme. Again the epitopes are discontinuous, but they involve 17-20 
residues from the antigen and form a surface area of around 850A2. 
In all five of the structures, the antigen interacts with either five or six of the 
antibody CDRs, and all of the combining sites contain a relatively large number of 
aromatic residues. Van der Waals contacts, hydrogen bonds and salt bridges 
contribute to the stabilisation of all of the complexes. A striking feature of the 
interaction of these Fabs with their protein antigens is the degree of structural 
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complementarity between the two surfaces. In all five cases this results in an almost 
total exclusion of water from the interface. It is believed that the entropic gain caused 
by the water exclusion contributes significantly to the stabilisation of the complex 
(Kauzmann, 1959). 
To date, relatively few Fab-protein structures have been determined at high 
resolution. This is partly to do with the fact that the Fab fragments, which are 
generally obtained by proteolytic cleavage with papain (Porter, 1959), exhibit 
considerable microheterogeneity. However with the development of molecular biology 
technology it is now possible to express recombinant Fab (Better et ai, 1988) and Fv 
(Riechmann et ai, 1988) fragments of antibodies. These methods of protein 
production have the distinct advantage that extremely homogeneous preparations of 
antibody fragments can be obtained. With improvements in the determination of Fab-
protein complex structures from crystallographic data (Cygler & Anderson, 1988) this 
should lead to the solution of a larger number of structures of antibody fragments, both 
free and bound, which will facilitate a more thorough investigation of the structural 
requirements for antibody-antigen binding. 
1.8 Definition of Epitopes 
There is an apparent discrepancy in size between the epitopes defined by X-ray 
crystallography, which contain 15-22 amino acid residues, and those identified by 
peptide scanning methods, which involve less than eight. However, an important 
distinction has to be drawn between the two techniques. The stereochemical 
information obtained from crystallographic data is entirely structural and gives no 
indication of the relative contribution of individual atomic interactions to the overall 
binding. The use of synthetic peptides identifies those residues which are directly 
involved in the binding interaction. Neighbouring residues are thought to be important 
in the intact protein to enable the contact residues to adopt their final conformation, 
although they do not contribute in a positive way to complex formation (Geysen el aI, 
1987). This view is supported by molecular modelling calculations which suggest that 
10 
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only a small number of amino acids, as few as 3-5, contribute the majority of the 
binding energy of the interaction (Novotny et aI, 1989). 
Consequently, the requirements for antibody binding can be described in terms 
of either a functional epitope, which contains those residues which interact strongly 
with the combining site, or a structural epitope, which includes all those residues which 
are spatially close to the binding site in the complex. 
1.9 Nuclear Magnetic Resonance Spectroscopy 
Nuclear magnetic resonance (n.m.r.) spectroscopy is a powerful tool for the 
investigation of the conformation and dynamics of small proteins and peptides in 
solution. Using two-dimensional (2D) n.m.r. techniques it is now possible to obtain 
structures at a resolution comparable to that achieved by X-ray crystallography of 
proteins up to a molecular weight of around 15,000. Although antibody-protein 
systems are too large for study by these methods, it is still possible to obtain a good 
deal of information, at somewhat lower resolution on the nature of the interactions 
within these complexes where the antigen involved is either a peptide (Arata et ai, 
1986 ; Anglister et ai, 1988), or a small protein (Paterson et ai, 1990). Even in these 
cases, to obtain the simplest n.m.r. spectrum possible, it is advantageous to work with 
the smallest easily obtainable fragment of antibody which retains its affinity for antigen, 
usually the Fab. A variety of different methods have been used to study these 
interactions (Anglister et ai, 1988; Kato et a/1989 ; Cheetham et aI, 1991 ; Tsang e/ 
aI, 1991), which yield information both on the identity of those residues in the antigen 
with which the antibody interacts and on the different strengths of interaction in the 
binding region. 
1.9.1 High Affinity Antibody-Peptide Complexes 
Due to the large size difference between antibodies (150,000 M.W.) and 
peptides (1000-3000 M.W.), their respective n.m.r. spectra are very different. 
Antibody proton resonances are broad with line widths >20Hz, whereas those of 
11 
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peptide protons are narrow <5Hz. In a high affinity complex, the peptide is in slow 
exchange between the bound and free states, and those residues of the antigen which 
interact strongly with the combining site become immobilised on binding. Thus in an 
n.m.r. spectrum of the complex. the resonances of the strongly interacting peptide 
residues assume the line width characteristics of antibody resonances, and are 
considerably broadened compared to those in the free peptide. Such changes in 
linewidth can be observed in a 2D-correlated spectroscopy (COSY) experiment (Aue 
et ai, 1976), since the cross peak intensity in the COSY experiment is dependent upon 
the line width (Weiss et ai, 1984). Hence it is possible to correlate cross peak 
intensities of resonances with the mobility of the residues from which they derive 
(Figure 1.4). 
Cheetham et al (1991) have used this method to identify the interacting 
residues of a 28-residue peptide derived from hen egg white Iysosyme, with the Fab of 
an anti-peptide antibody, and observed a number of strongly interacting residues. In the 
intact lysosyme molecule, for which an X-ray crystal structure is available (Handoll, 
1985), the residues identified as being tightly bound in the complex. although distant in 
the primary sequence, are grouped together in the tertiary structure to form a 
hydrophobic projection on the surface of the molecule. Consequently this method 
provides a means of identifying the degree of mobility of residues in a peptide antigen 
bound within the combining site of a high affinity antibody. Since this mobility can be 
correlated with the nature of the peptide interactions with the antibody in the complex. 
it offers an insight into the conformational and dynamic features of antibody specificity. 
1.9.2 Low Affinity Antibody-Peptide Complexes 
For low affinity complexes, where the peptide is in fast exchange between the 
bound and free states, those residues which interact with the antibody combining site 
can be identified using transferred nuclear Overhauser effect (TRNOE) spectroscopy 
(Balaram et ai, 1972). By acquiring 2D TRNOE spectra at different molar ratios of 
F ab : peptide, it is possible, by subtraction, to obtain a spectrum in which all the cross 
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peaks represent magnetisation transfers from antibody combining site to bound peptide 
protons (Anglister el ai, 1988). This provides information on the distances between 
protons of the antibody and peptide in the bound state. The number of NOEs 
observed in such experiments is generally insufficient to define the conformation of the 
complexes. Therefore, distance constraints derived from the n.m.r. data are used in 
conjunction with molecular modelling to obtain a three dimensional structure of the 
antibody bound peptide. 
Figure 1.4 
fI 
t 
c 
Free peptide 
c f1 
a t 
Pab-peptide complex 
COSY spectrum. of free peptide 
~ ~ f2 
b 
C) 
a 
CO SY spectrum. of complex 
Schematic illustration of the study of high affinity Fab-peptide 
complexes using 2D COSY. In the complex, (a) represents a weakly 
bound residue; (b) a tightly bound residue; and (c) an unbound residue. 
The effect of binding on the intensity of the COSY cross peaks is 
shown. f1 and f2 represent the two frequency axes in the n.m.L 
spectrum. 
/3 
('hapler 1 - IllIrodliClioll 
These methods have been used to study a number of complexes involving a 
peptide derived from cholera toxin, CTP3, with Fab fragments of three antibodies, 
TE32, TE33 and TE34, raised against it (Anglister el ai, 1988, 1989, 1990 ~ ~ Levy el 
ai, 1989 ~ ~ Zitber el ai, 1990). In all three complexes the peptide folds into a loop on 
binding to the antibody fragment, and interacts with four or five of the CDRs. This 
increases the surface area of contact between antibody and antigen, thereby potentially 
increasing the binding energy. The surface area of the interaction is 380A2 for TE34 
(Zilber el ai, 1990), and around 480A2 for TE32 and IE33 (Scherf el ai, 1992). The 
smaller surface area of interaction is thought to be a feature of antibodies raised against 
peptide antigens rather than large globular proteins. Indeed the shape of the combining 
sites of these anti peptide antibodies is significantly different from those for protein 
antigens. Anti-protein antibody combining sites tend to be rather flat, with 
protuberances and depressions which fit the shape of the antigen (reviewed in Wilson 
et ai, 1991). In contrast, the anti-peptide antibodies contain a pocket or groove which 
interacts with the antigen over a much smaller area (Zitber et ai, 1990). 
Interestingly, two of the antibodies raised against CTP3, namely TE32 and 
TE33, cross react with the intact cholera toxin, whereas TE34 does not (Anglister et 
ai, 1988). The peptide adopts a very similar structure when bound to either TE32 or 
TE33 (Scherf et ai, 1990), however the structure of the TE34/CTP3 complex is 
significantly different. This suggests that the loop structure of the peptide found in the 
complexes with TE32 and TE33 may be present at the surface of the intact cholera 
toxin. 
1.9.3 Isotope Edited N.M.R. Studies 
Recent advances in methodology have extended the applicability of n.m.r. 
spectroscopy to proteins with a molecular weight of up to 30,000 (Clore & 
Gronenbaum, 1992). With the development of recombinant DNA technology, which 
has enabled the expression of Fv fragments of antibodies in A ~ · c h e r i c h i a a coli (Huston 
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et al. 1988) or myeloma cells (Reichmann et ai, 1988), it should now be possible to 
obtain high resolution structures ofFv and Fv - peptide complexes from n.m.r. data. 
Early studies of an engineered anti-Iysosyme Fv fragment confirmed that 
unambiguous resonance assignments could be obtained for proteins of this size by 
isotopically enhancing the protein with 15N and l3C labels (Wright et al. 1990). More 
recently, Takahashi et 01 (1992) have investigated the conformational changes in the 
combining site of an anti-dansyl monoclonal antibody upon antigen binding. In this 
case the antigen interacts strongly with only one of the six CDRs, and although 
considerable changes occur in the quaternary structure of this region upon antigen 
binding, it is not yet clear to what extent this is a general phenomenon, or whether it is 
a special case for antibodies binding to small molecules. 
Isotope edited techniques have also been used successfully to investigate the 
conformation and dynamics of peptide antigens when bound to antibody (Tsang et 01, 
1990, 1992). By labelling the peptide with 15N and l3C it is possible to selectively 
observe the resonances of peptide protons in the combining site. Tsang et al (1992) 
have shown that a peptide derived from myohemerythrin adopts a helical backbone 
conformation in the combining site of an anti-peptide Fab (813A2). In the X-ray 
crystal structure of myohemerythrin, the region corresponding to the peptide is also 
helical (Fieser et 01, 1987). This may explain the observed cross-reactivity of B 13 A2 
with the intact protein. In addition, it has been reported that the free peptide in 
aqueous solution has a propensity to form a nascent helix (Dyson et ai, 1988). Thus it 
appears that on binding to antibody the peptide is stabilised in a helical conformation. 
1.10 Concluding Remarks 
The ability to characterise the structure and dynamics of antibody combining 
sites and antigens, both free and in complexes, is of fundamental importance to an 
understanding of antibody specificity. Improvements in the methodology, both for 
obtaining binding fragments of antibodies, and in determining their conformation, have 
enabled new insights to be gained into the structural aspects of antibody-antigen 
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complexes. The increased availability of engineered Fv fragments and the further 
refinement of these techniques should facilitate a greater understanding of the 
molecular basis of antibody-antigen interactions. 
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POLYMORPHIC EPITHELIAL MUCINS 
Chapter 2 - Introduction 
2.1 General Characteristics of Mucins 
Many epithelial cells are covered by a protective secretion which serves as a 
selective barrier between the plasma membrane and the environment of the cell. This 
secretion, usually called mucus, is a highly hydrated gel comprising a large number of 
components. The predominant macromolecules in this secretion are the mucins. 
The mucins can be divided into two general categories. Secretory mucins 
constitute the major component of the viscous gels which cover the mucosal secretions 
of respiratory, gastro-intestinal and reproductive tracts. The secretory mucins have the 
ability to form intermolecular disulphide bridges resulting in the formation of 
oligomeric structures, which confer on the mucus its protective and lubricative 
properties (Allen, 1983). Membrane-bound mucins are structurally similar, however 
they exist in a monomeric form and their polypeptide backbone has a hydrophobic 
segment which serves to anchor the molecule in the plasma membrane (Gendler et aI, 
1990). The precise function of these membrane bound mucins remains unclear. 
2.2 Physical and Chemical Properties of Mucins. 
Mucins are high molecular weight glycoproteins which consist of a non-
globular polypeptide backbone (Eckhardt et aI, 1987) to which oligosaccharides are 
attached via the hydroxyl groups of serine and threonine. The central portion of the 
protein core contains regions which are especially rich in serine and threonine residues. 
virtually all of which are glycosylated, while the terminal parts of the backbone consist 
of a more normal distribution of amino acids. All mucins have a similar amino acid 
composition. They are rich in aliphatic amino acids, but contain a low percentage of 
aromatic and sulphur containing residues (Herp et aI, 1979 ; Carlstedt et aI, 1983). 
Serine, threonine, alanine, glycine and proline particularly dominate the backbone, 
comprising around 50% of the amino acids. 
The majority of the sugars on mucins are attached to the hydroxyl oxygen of 
serine and threonine residues via N-acetyl galactosamine (GalNAc) (Figure 2.1a). The 
oligosaccharide chains vary greatly in length and consist of up to 20 residues (Gendler 
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el ai, 1988). The pattern of glycosylation is non-uniform, with some regions being 
heavily glycosylated, while others are virtually free of carbohydrate chains (Roberts, 
1976). Five different monosaccharide units are commonly found, namely N-acetyl 
galactosamine, N-acetyl glucosamine (GlcNAc), galactose (Gal), fucose (Fuc) and 
sialic acid (SA). In addition the mucin contains variable amounts of sulphate, which is 
normally attached to Gal, GalNAc or GIcNAc. The presence of the sialic acid and 
sulphate moieties confer a negative charge on these molecules, which are thought to be 
important in maintaining the extended rod-like conformations seen in the mature 
mucins (Section 2.7). N-linked oligosaccharides have been shown to be present in 
some mucins (Denny & Denny, 1982 ; Hilkens & Buijs, 1988). These N-linked 
glycans are normally attached through the amide nitrogen of asparagine to GlcNAc 
(Figure 2.1 b). However these represent only a minor fraction of the total carbohydrate 
content. 
~ ~
X NH 
I I 
O-CH-CH 
I 
c=o 
~ ~
NH 
I 
c=o 
I 
CHJ 
Figure 2.1a N-Acetyl Galactosamine 
linked to a serine (X=H) or threonine 
(X=CH3) residue. 
~ ~
H NH 
I I 
N-C-CH:r-CH 
II I 
o c=o 
~ ~
NH 
I 
c=o 
I 
CH3 
Figure 2.1 b N-Acetyl Glucosamine 
linked to an asparagine residue. 
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Secretory mucins are distinct from the membrane bound molecules in that they 
contain cysteine residues in the terminal parts of the protein core which allow them to 
oligomerise through the formation of disulphide bridges (Allen. 1983). In contrast 
membrane bound molecules exist as monomers, and contain a hydrophobic trans-
membrane domain which anchor the molecule in the membrane (Gendler et ai, 1990). 
2.3 Human Mammary Mucin 
In recent years there has been considerable interest 10 a group of human 
epithelial mucins. This has primarily been due to the fact that antibodies directed to 
specific epitopes on these molecules have been widely used for both ill vivo and ill 
vitro diagnosis of cancer (Table 2.1). One such mucin, derived from mammary 
epithelia has been widely investigated. 
2.4 Nomenclature 
There is considerable disagreement in the literature as to the name of the 
mammary mucin. Shimizu & Yamauchi (1982) originally termed it P AS-O, however, 
various different groups have since developed there own nomenclature. It has been 
designated as epithelial membrane antigen (EMA) (Heyderman et aI, 1979), non 
penetrating glycoprotein (NPGP) (Ceriani et aI, 1983), peanut lectin binding urinary 
mucin (PUM) (Swallow et ai, 1986), episialin or MAM-6 (Ligtenberg et ai, 1990), 
mammary serum antigen (MSA) (Stacker et aI, 1988), DF3 antigen (Siddiqui et aI, 
1988) and Ca antigen or epitectin (Bramwell et aI, 1983, 1986). In an attempt to 
resolve the confusion the name polymorphic epithelial mucin (PEM) was suggested 
(Gendler et aI, 1988), as this was believed to describe the biochemical characteristics 
of the molecule. However, since the discovery of a number of other mucins with 
similar properties a new terminology has been developed. The family of mucins are 
now designated MUC, followed by a number, which reflects the order in which the 
gene coding for the protein was sequenced (Gum et ai, 1990). Thus, the mammary 
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mucin is MUC 1, since this was the first mucin for which partial cDNA clones were 
obtained and sequenced. 
Table 2.1 Clinical applications of anti-MUC 1 antibodies. 
Technique Application Reference 
Immunohistology Identification of cancer reviewed in Zotter et 
cells in biopsy specimens ai, 1988 
Radioimmunoassay Diagnostic and prognostic reviewed in Kenemans 
indicator for advanced et ai, 1988 
breast cancer 
Radio-immunoscintigraphy Imaging of ovarian tumours Symonds et ai, 1992 
Radio-8!!ided surse!! 
2.5 Biochemical Aspects of MUCI 
In nonnal tissues MUC 1 is found on the apical borders of highly specialised 
secretory epithelial cells, however in malignancy it appears to be up-regulated and 
aberrantly expressed (Burchell et ai, 1987), and has been shown to be present in 
elevated levels in the serum of patients with advanced breast cancer (Price et ai, 1988). 
Consequently, antibodies raised against the mucin have a number of applications in the 
management of cancer patients (Table 2.1). 
MUC 1 exhibits the general features of a mucin glycoprotein, having a high 
molecular weight, and containing a high proportion of carbohydrate, which is O-linked 
to serine and threonine residues in its single polypeptide backbone. The protein has 
been shown to exhibit extreme size polymorphism which is demonstrable at the DNA 
(Swallow et ai, 1986) and protein (Gendler et ai, 1988) level. Full length cDNA 
clones coding for the polypeptide backbone of MUC 1 have now been obtained and 
sequenced (Gendler et ai, 1990), and the protein core contains a number of distinct 
regions (Figure 2.2). The bulk of the core consists of varying numbers of a highly 
conserved twenty amino acid tandem repeat sequence, the tandem repeat continues 
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into the terminal domains of the protein core becoming increasingly less degenerate. 
The N-terminal sequence has a hydrophobic signal peptide, which is probably cleaved 
in the mature mucin and the C-terminal domain contains a hydrophobic membrane 
spanning sequence and a cytoplasmic tail (Gendler e/ ai, 1990). The basis of the 
polymorphism lies in the expression of different numbers of the tandem repeat. 
Analysis of genomic DNA from a variety of individuals has revealed that MUC 1 may 
contain between 25-125 copies of the tandem repeat (Gendler el ai, 1988). 
Figure 2.2 
N c 
Diagram of the MUC 1 core protein showing the N-terminal signal 
peptide < < ~ b , , tandem repeat region (.), C-terminal transmembrane 
domain (III) and cytoplasmic tail ( ~ ) . . N and C refer to the N- and C-
termini of the polypeptide chain. 
The ammo acid composition of the protein core IS dominated by the 
composition of the tandem repeat (Table 2.2), and is typical of a mucin glycoprotein. 
Proline, alanine, glycine, serine and threonine account for around 60% of the amino 
acids. All of the cysteine residues in the backbone are contained within the membrane 
spanning domain, consequently MUC 1 does not have the capacity to form disulphide-
linked oligomeric structures (Gendler et ai, 1990). The tandem repeat sequence 
(Figure 2.3) contains 25% serine and threonine residues, which gives this portion of 
the molecule the potential to be highly glycosylated. Potential O-glycosylation sites 
are also present outside the tandem repeat region, and five putative N-glycosylation 
sites have been identified in the C-terminal sequence (Gendler el ai, 1990). 
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Table 2.2 Amino acid composition of the translated DNA sequence of MUC 1 
containing 42 tandem repeats. 
Amino Acid Composition (%) Amino Acid Composition (%) 
Alanine 16.1 Leucine 2.7 
Arginine 4.2 Lysine 0.8 
Asparagine 1.4 Methionine 0.3 
Aspartic acid 4.5 Phenylalanine 1.3 
Cysteine 0.2 Proline 19.0 
Glutamic acid l.0 Serine 12.2 
Glutamine 1.3 Threonine 13.5 
Glycine 8.9 Tryptophan 0.2 
Histidine 4.5 Tyrosine 1.0 
Isoleucine 0.9 Valine 6.0 
The pattern of glycosylation of MUC I is extremely heterogeneous, with 
carbohydrate chains differing in both length and sugar composition. Unlike N-linked 
glycans, where oligo saccharides are attached to asparagine residues in the sequence 
Asn-X-SerITbr, where X can be any amino acid other than proline or aspartic acid 
(Marshall, 1972), no consensus sequence for O-glycosylation has been identified. 
However it has been suggested that the serines and threonines should be adjacent to 
either themselves or one another in order to be glycosylated (Timpte et ai, 1988) and 
that proline must reside near to glycosylation sites (Takahashi et aI, 1984 ; Briend et 
ai, 1981). Four of the five serine and threonine residues in the tandem repeat comply 
with these requirements (Figure 2.3). Recently, it has been shown that the mucins 
expressed by pancreatic and ovarian tissues have the same polypeptide backbone as the 
mammary mucin. However the pancreatic mucin has reported molecular weights of up 
to 1,000,000 and is more extensively glycosylated (Lan et ai, 1987). Consequently it 
appears that the glycosylation is tissue specific and may not be determined entirely on 
the basis of the protein sequence. 
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PDTRPAPGSTAPPAHGVTSA 
20 
Figure 2.3 Sequence of the twenty amino acid tandem repeat indicating probable 
O-glycosylation sites (e). 
It is thought that MUC 1 is expressed in an under-glycosylated form by 
tumours. Analysis of the carbohydrate chains of normal milk mucin have been found 
to contain between 8-14 oligo saccharides (Hanisch et aI, 1989), whereas those of 
mucin from a breast cancer cell line consisted of as few as two (Hull et aI, 1989). 
Further indirect evidence for this has come from the observed pattern of reactivity of 
monoclonal antibodies raised against either deglycosylated mucin, or peptides relating 
to the tandem repeat. These antibodies have been shown to react with mucin from 
tumour cells but not the normal mucin (Girling et aI, 1989 ~ ~ Perey et aI, 1992), 
supporting the idea that in the cancer-derived material, aberrant glycosylation results in 
the exposure of epitopes in the MUCI protein core (Figure 2.4). Clearly a knowledge 
of the precise determinants identified by the anti-MUC 1 antibodies may allow 
identification of tumour associated epitopes and could yield information regarding the 
pattern of glycosylation of mucin obtained from different sources. 
2.6 Epitope Mapping of Anti-MUel Antibodies 
MUC 1 has been identified as the target antigen for a number of murine 
monoclonal antibodies raised against a variety of immunogens such as human-milk 
products (Taylor-Papadimitriou et aI, 1981 ; Burchell et ai, 1987) and breast tumour 
extracts (Ellis et aI, 1984). Some of the antibodies appear to recognise tumour 
associated epitopes and there has been considerable interest in characterising these 
determinants as this may provide a clearer understanding of the specificity of the 
antibodies for malignant cells. 
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A number of anti-MUC 1 antibodies recognise epitopes within the carbohydrate 
chains of the mucin (O'Sullivan. 1990). A thorough consideration of the carbohydrate 
epitopes expressed by MUC 1 is beyond the scope of this thesis, and has been 
comprehensively reviewed elsewhere (Zotter et ai, 1988). It has been found that many 
antibodies react with deglycosylated mucin preparations (O'Sullivan. 1990), indicating 
that their epitopes are contained within the protein core of MUC I. Hence it appears 
that even in the intact mucin, which is extensively glycosylated, regions of the 
polypeptide backbone are accessible to antibody binding. Since the sequence of the 
MUCI core protein was reported (Gendler et ai, 1988), it has been possible to define 
the precise determinants of a number of these antibodies. 
Table 2.3 Epitopes ofa number ofanti-MUCI monoclonal antibodies. 
Antibody Epitope Reference 
BC 1, BC2, BC3 APDTR Xing et ai, 1991 
SM3 PDTRP Burchell et aI, 1989 
Price et ai, 1990b 
HMFGl PDTR Burchell et ai, 1989 
HMFG2, EMA M8, DTR Burchell et ai, 1989 
RINA 9/22, RINA 5/2 Price et aI, 1990b 
Taylor-Papadimitriou et ai, 1991 
BrE-2,BrE-3 TRP Taylor-Papadimitriou et ai, 1991 
onc-MIS TRPA Burchell et ai, 1989 
Ca-2 TRPAP Price et aI, 1990b 
NCRC-II RPA Price et ai, 1990b 
C59S,789/91,F36/22 RPAP Burchell et ai, 1989 
Price et ai, 1990a 
Taylor-Papadimitriou et ai, 1991 
Using a series of tethered synthetic peptides it has been shown that several 
antibodies recognise epitopes contained within the tandem repeat domain of the MUC 1 
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protein core (Xing et 01, 1990; Briggs et ai, 1992). The presence of multiple copies of 
the tandem repeat in the intact mucin give this region the potential to be highly 
immunogenic. The epitopes consist of 3-5 amino acid residues within a discreet region 
of the repeat sequence, APDTRPAPG (Table 2.3). Interestingly, all of the residues 
contain the central arginine residue of this sequence, however, it appears that they can 
be subdivided into two major categories. Ten of the antibodies contain the motif OTR 
within their epitopes. Interestingly, all of these antibodies were prepared against either 
human milk derived products or breast glycoprotein. The majority of the remaining 
antibody epitopes contain the sequence RP A. These antibodies were raised against 
either purified mucins or tumour tissue. Whether the accessibility of the different 
immunogenic epitopes varies in mucin derived from different sources has yet to be 
determined. 
It is clear that the interaction of antibodies with as few as three sequential 
residues of the tandem repeat is fundamental to the process antigen recognition and 
binding. Indeed it has been shown that it is possible to replace individual amino acids 
contained in the epitopes of some antibodies with structurally unrelated residues 
without affecting the binding (Xing et 01, 1990 ; Briggs et ai, 1991, 1992). Hence it 
appears that not all of the residues defined in the epitope are directly involved in the 
binding process. However, estimates of the size of antibody binding sites obtained 
from X-ray crystallography (Section 1.7) and n.m.r. data (Section 1.9) suggest that 
\ 
additional factors are almost certainly involved in antibody recognition of the MUC 1. 
Residues flanking the defined epitopes and carbohydrate side chains present in the 
intact mucin are likely to impose conformational restraints on the determinant which 
affect its presentation and recognition by antibody. It has been shown that substitution 
of the proline residue in the tetrapeptide PDTR by any other residue results in a loss of 
binding to the antibody HMFG2 (Briggs et ai, 1991), even though the proline is not 
contained within the defined epitope (Table 2.3). This highlights the importance of 
presentation of the epitope in the correct conformation for antibody binding. 
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It is not yet known to what extent the carbohydrate side chains present in the 
intact mucin contribute to the overall binding. Since the immunodominant sequence in 
the tandem repeat contains one possible O-g1ycosylation site and is flanked by several 
others it is likely that g1ycosylation of these residues will restrict the accessibility of this 
sequence to antibodies. Aberrant or under-g1ycosylation of the carcinoma-derived 
mucin is believed to result in more of the protein core becoming accessible. This is 
thought to account for the observed tumour specificity of the antibody SM3 which 
defines the epitope PDTRP (Gendler et ai, 1990). It has been suggested that the 
threonine residue in the immunodominant sequence cannot be g1ycosylated in the intact 
mucin since this residue is contained in the epitopes of a number of anti-MUC 1 
antibodies. However, replacement experiments based on the technique of Geysen et al 
(1987) have revealed that substitution of the threonine by almost any other amino acid 
has little effect on the binding of antibodies HMFGl and HMFG2 (Briggs et ai, 1991). 
Consequently, it may be possible to accommodate a carbohydrate chain at this 
position. 
Further studies on the structure of the mucin and peptides based on the tandem 
repeat sequence may provide a clearer insight into the conformational requirements for 
antibody recognition and binding. 
2.7 Structural Studies of MUCI 
Due to the size and complexity of the intact MUC 1 molecules, attempts to 
define their structure in detail have been only partially successful. Electron microscopy 
studies of MUC 1 molecules have suggested that the mucin is rod-shaped (Slayter & 
Codington, 1973), random coils (Rose et ai, 1984) or single non-linear extended 
strands (Bramwell et ai, 1986). It is not clear to what extent the sample preparation in 
these studies affects the observed structure, however it appears that the molecules exist 
in extended conformations. More recently, images of MUC 1 obtained from ovarian 
carcinoma ascitic fluid have been imaged using scanning tunnelling microscopy (STM) 
(Roberts el ai, 1992). Unlike electron microscopy, STM has the advantage that 
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biomolecules can be directly observed under ambient conditions. The ovanan 
carcinoma MUC 1 were found to be rod-shaped molecules of mixed length which 
aggregate along their long axis (Roberts et al. 1992). Aggregation of membrane 
bound mucin in this manner has previously been suggested as the mechanism by which 
the MUCI molecules protect the underlying epithelia (BramweH et al. 1983). 
Although these studies provide information on the surface topography of the 
mUCIn molecules. the resolution of the techniques is not sufficient to probe the 
structural features of the antibody binding domain found in the tandem repeat. 
Furthermore the large size and heterogeneity of the intact mucin make it unsuitable for 
investigation by more conventional techniques such as X-ray crystallography and 
n.m.f. spectroscopy. Consequently a number of structural investigations have been 
carried out on polypeptide sequences derived from the MUC} protein core. 
Hydropathicity calculations (Kyte & Doolittle. 1982) performed on a 60 amino 
acid polypeptide corresponding to three copies of the MUC} tandem repeat sequence 
(Figure 2.3) indicated the presence of a hydrophilic domain extending over seven 
residues, PDTRP AP (Price et ai, 1990a). These results suggest that this region is 
likely to be expressed at the surface of the intact MUCI molecule where it would be 
accessible to antibody binding. The hydrophilic domain overlaps the identified 
immunogenic region of the MUC 1 core protein. Secondary structure predictions 
(Chou & Fasman, 1978) indicate that within the hydrophilic domain there is a high 
potential for fj-tum formation (Price et al. 1990a). It has been suggested that 
secondary structure motifs such as fj-tums may be involved in antibody recognition of 
antigens (Williamson et aI, 1986; Tendler, 1990; Dyson el aI, 1990). N.m.r. studies 
on peptides based on the tandem repeat sequence have identified the presence of a 
number of secondary structure features including a type I fj-tum in the hydrophilic 
domain which overlaps the epitopes of all the protein-core-reactive anti-MUC 1 
antibodies characterised to date (Tendler, 1990 ; Scanlon et ai, 1992). Further 
investigations of the structure of peptides based on the MUC} tandem repeat 
sequence, which have been shown to react with anti-MUC} antibodies (Xing et ai, 
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1991 ~ ~ Briggs et ai, 1991, 1992 ~ ~ Scanlon et ai, 1992), may provide an insight into the 
conformational requirements for antibody recognition and a clearer understanding of 
the basis of the tumour specificity of some of the antibodies. 
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SOLUTION CONFORMATIONS OF LINEAR PEPTIDES 
Chapter 3 - introduction 
3.1 Overview 
Until relatively recently it was generally believed that short linear peptides 
existed as random structures in solution. Early theoretical calculations (Brant et ai, 
1967) and experimental methods using spectroscopic techniques (Epand & Scheraga, 
1968 ; Hermans & Puett, 1971) confirmed this view. However an apparent exception 
to this rule was discovered when Brown & Klee (1971) showed that under certain 
conditions the S-peptide, the N-terminal 20 residues of ribonuclease, gave a circular 
dichroism (CD) spectrum which indicated a low population of a helix . Subsequently a 
whole range of peptides have been found to exhibit local conformational preferences in 
solution (reviewed in Wright et ai, 1988). It is now widely accepted that peptides exist 
in solution as a number of rapidly interconverting conformers. If one of these 
conformations is sufficiently long lived it may be possible to detect it by a number of 
techniques. A variety of spectroscopic methods have been used to investigate the 
solution conformations of linear peptides including circular dichroism (CD), vibrational 
spectroscopy (Fourier transform infra-red (FTIR), Raman) and n.m.r. If the 
polypeptide backbone is assumed to consist of planar trans peptide bonds linked via 
the a-carbon atom, then possible conformations of a polypeptide can be described by 
the angles </>, t/; and X (Figure 3.1). 
Figure 3.1 Standard nomemclature for atoms and bond angles in peptides. 
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Peptides in solution normally adopt a limited range of structures, these are the 
random coil, - a term which implies that no single conformation is particularly stable -
the ex helix, and the type-I and type-II IJ-tums (Figure 3.2) . 
Figure 3.2 
• o 
Elements of secondary structure commonly found in peptides, the ex 
helix (a), and the type-I (b) and type-II (c) IJ-tums. Dotted pink lines 
represent hydrogen bonds. 
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3.1.1 Circular Dichroism 
CD spectroscopy is a widely used technique for determining elements of 
secondary structure present in polypeptides. For large proteins characteristic spectra 
corresponding to different structural features are well understood (reviewed in 
Johnson, 1990). Although the same characteristic spectra might be expected for 
peptides, it has been found that small deviations from the ideal dihedral angles found in 
the different elements of secondary structure cause significant perturbation of the CD 
signal (Manning & Woody, 1989). However a number of peptides have been 
described which exhibit spectra characteristic of ex helices (Manning et al. 1977 ~ ~
Goodman, 1990) type I p-tums (Gierasch et ai, 1981 ~ ~ Bandekhar et al. 1982) and 
type II p-tums (Woody, 1974). 
3.1.2 Vibrational Spectroscopy 
The application of Raman and FTIR spectroscopy to conformational studies of 
peptides and proteins has been extensively reviewed by Krimm & Bendekhar (1986). 
Certain characteristic bands in the spectra have been shown to be sensitive to local 
conformation in the peptide. Stretching vibrations of the backbone carbonyl groups 
give rise to the amide I band. The frequency of the vibration depends on the nature of 
the hydrogen bonding at the site, which is largely determined by the secondary 
structure in which it is involved. In addition the amide III band. which arises from NH 
in-plane bending has been shown to be sensitive to local conformation (Diem et ai, 
1984 ; Oboodi et ai, 1984 ; Roberts et ai, 1988). Consequently these methods can 
provide information regarding elements of secondary structure present. 
3.1.3 Nuclear Magnetic Resonance Spectroscopy 
N.m.r spectroscopy is probably the most widely used technique for elucidation 
of peptide structures in solution. The major advantage of n.m.r. is that the information 
it provides is site-specific. An important difference between n.m.r. and the other forms 
of spectroscopy lies in the timescales of the different techniques. The various forms of 
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optical spectroscopy can distinguish conformations which interconvert on a sub-
picosecond timescale, therefore they are capable of providing information on the 
relative populations of different elements of secondary structure present in a peptide in 
solution. N.m.r. spectroscopy is only capable of detecting exchange processes which 
occur on the millisecond-to-second timescale, and consequently it is rarely possible to 
deduce the populations of the different conformations directly from n.m.f. data. 
However if one of the conformers in the conformational ensemble sampled by the 
peptide is particularly stable, then it may be possible to characterise using n.m.r. 
3.2 Characterisation of Peptide Structure by Nudear Magnetic: Resonance 
Spectroscopy 
The important parameters of the three isotopes which are ubiquitous in 
peptides and are widely observed in n. m.f. experiments are listed in Table 3.1. Due to 
its high natural abundance the 1 H nucleus can be detected with far greater sensitivity 
than either l3C or lSN. Consequently the vast majority of work relies on the 
observation of IH resonances and the following discussion relates to IH-n.m.r. 
spectroscopy. 
Table 3.1 Nuclear properties of selected isotopes. 
Isotope Spin (I) Observation Natural Relative 
frequency at abundance sensitivity 
1l.74T (MHz) 
IH 112 500.0 99.98 1.00 
l3C 112 125.7 1.11 1.8xl0-4 
lSN 112 50.7 0.37 3.8xIO-6 
The determination of peptide conformations in solution relies upon the 
interpretation of spectral parameters such as chemical shift (0), coupling constants (J) 
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and nuclear Overhauser effects (NOEs). The main problem in interpreting these 
parameters is that the data obtained reflects a population weighted average of all the 
conformations present in the peptide. Since the different parameters are averaged in a 
non-linear way, it is not usually possible to deduce the nature of all of the constituent 
conformers from the averaged data. For example, the intensity of a NOE between two 
nucleii depends not on the internuclear distance (r), but on r-6, thus a minor conformer 
can still give a strong NOE even after conformational averaging. Therefore when 
attempting to identify a preferred structure from the n.m.f. data, it is necessary to 
adopt a cautious approach, acquiring as much information as possible and ensuring that 
evidence for a particular conformation comes from as many different sources as 
possible. The following section contains a brief description of those IH n.m.r. 
parameters which are fundamental to the problem of structure determination. 
3.2.1 Chemical Shift 
The chemical shift (0) of a proton resonance depends upon its chemical 
environment. Thus the position of a resonance in the spectrum is characteristic of the 
type of proton that it is associated with (Figure 3.3). In an unstructured peptide, 
protons have chemical shifts which depend upon the amino acid type and values of 
these so-called random coil shifts have been tabulated (Wiithrich, 1986). Deviations of 
the chemical shift from these values may suggest the presence of a preferred structure 
in the peptide, although they provide no indication of what that structure may be. 
10 
Figure 3.3 
IIIIlIIll 
5 o 
o (ppm) 
Typical resonance positions of protons in common amino acid residues. 
III backbone NH; III side chain NH; rIJ a ; I§I {3; 111 methyl; 
• aromatic ring; II other aliphatic. 
Chapter 3 - Introduction 
3.2.2 Temperature Dependence of Amide Proton Chemical Shifts 
The amide proton temperature coefficient ( ~ O / / ~ ~T) is the rate at which an 
amide proton resonance moves upfield with increasing temperature. Solvent exposed 
amide protons have a coefficient of 6-8 ppb/K. A lower value suggests that the proton 
is shielded from solvent in some way, and is widely used as a measure of the extent of 
hydrogen bonding (e.g. Williamson el ai, 1986 ~ ~ Dyson el ai, 1988a ~ ~ Tendler 1990). 
Since the different elements of secondary structure have characteristic patterns of 
hydrogen bonding (Figure 3.2) this parameter can provide information regarding 
preferred conformations in a peptide. 
3.2.3 Coupling Constants 
The value of the vicinal coupling constant e J) varies in a complicated fashion 
depending upon the angle between the two protons (pardi et ai, 1984 ~ ~ Figure 3.4). 
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Figure 3.4 Variation of 3 JHNa with dihedral angle for peptides. 
The coupling constant between the amide and a protons (3 JHNa) of an amino 
acid residue varies with the angle 4> (Figure 3.1). Since the backbone conformation of 
a peptide can be described by the angles 4> and tjI the coupling constant can provide 
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valuable structural information. However it must again be stressed that since rotations 
about single bonds, and hence changes in the angle between two protons, occur on a 
very much faster timescale than the n.m.f. experiment, the measured coupling constant 
is an average value. So although there are characteristic values of 3 JHNa for particular 
secondary structures (Table 3.2), even if the observed value suggest the peptide is 
unstructured it does not preclude the presence of minor populations of stable 
conformers. 
Table 3.2 Characteristic angles and coupling constants in secondary structures. 
Structure Residue Residue 
(i+l) (i+2) 
" 
3JHNo 
" 
JJUNo 
ex helix -57 -47 3.9 
random coil 6.5-8.5 
type-I p tum -60 -30 4.6 -90 0 7.9 
type-II p tum -60 120 4.6 80 0 6.2 
3.2.4 Nuclear Overhauser Effects 
The NOE is the most important parameter in defining structure as it provides 
direct information on the distance between two protons. If one of the proton 
resonances is pre-irradiated, it causes a change in the intensity of the resonance line 
observed for the other. Such a change in the intensity of a signal in an n.m.r. spectrum 
is called a NOE. The intensity of a NOE is highly sensitive to the distance between the 
two protons involved, and varies as r6, where r is the distance between the two 
protons. The observation of a NOE between a given pair of protons in a linear peptide 
indicates the presence of at least a threshold population of conformers in which these 
protons are separated by less than approximately 3.5A (Dyson el ai, 1988a, 1988b). 
The distances between two hydrogen atoms A and B located in the amino acid residues 
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at positions i and j in the sequence of a polypeptide is conventionally denoted dAB{i,j) 
as shown in Table 3.3. In practice the distances between certain protons in the peptide 
are of particular interest, and these are denoted as shown below: 
daN - distance between aH j and NHi+ I 
dNN - distance between NH j and NH j+ I 
dfjN - distance between fjH j and NHi+1 
Within the elements of secondary structure commonly found in peptides there 
are characteristically short interproton distances (Table 3.3). Thus an analysis of the 
pattern of NOEs provides direct information on conformations present in a peptide. 
However as the NOE data contains contributions from a variety of different 
conformers, great care has to be taken in the interpretation of the data to ensure that 
the observed NOEs result from a single conformation. 
Table 3.3 Short distances in secondary structures. Those distances which are 
short enough for an NOE to be observed in a linear peptide are 
underlined. 
Distance (A) a helix Type-I p-tum Type-n p-tum 
daN (i,i+l) 3.5 3.4 2.2 
daN (i+ 1 ,i+2) 3.2 3.2 
daN (i,i+2) 4.4 3.6 3.3 
daN (i,i+3) 3.4 3.1-4.2 3.8-4.7 
daN (i,i+4) 4.2 
dNN (i,i+l) 2.8 2.6 4.5 
dNN (i+ l,i+2) 2.4 2.4 
dNN (i,i+2) 4.2 3.8 4.3 
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3.3 Sequence Specific Assignments 
Before any of the parameters described above can be interpreted, it is necessary 
to assign the individual resonance lines in the spectrum to specific protons in the 
peptide. The assignment procedure relies upon the analysis of scalar coupling patterns 
and NOEs (Wuthrich, 1986). In n.m.r. spectra of peptides the observation of IH-IH 
couplings is limited to protons which are separated by two covalent bonds (geminal 
couplings, 21) or three covalent bonds (vicinal couplings, 3J). As the protons on 
adjacent residues in a peptide are separated by a minimum of four covalent bonds, 
scalar IH-IH couplings are only observed between protons within the same amino acid 
residue. A group of resonances which are connected by scalar couplings are referred 
to as a spin system. Thus the protons of each amino acid residue constitute one or 
several spin systems. 
3.3. t Spin System Nomenclature 
Amino acid spin systems are conventionally denoted by a series of upper case 
letters corresponding to protons with different chemical shifts (pople et ai, 1959). The 
proton which resonates at the highest field is listed first, and the remaining spins are 
placed in order from the periphary towards the aH. Brackets indicate that the spin 
network is branched and those spins in the parentheses are listed in the direction away 
from the aH. Neighbouring letters in the alphabet indicate strongly coupled spins 
where the chemical shift difference between the two resonances (ao) is comparable to 
the coupling constant (1). Conversely non-neighbouring letters indicate weakly 
coupled spins (ao »J). Thus for proline which has the spin system A2(T 2)MPX 
(Table 3.4) the two -yH are equivalent and resonate at the highest field and are denoted 
A2. The spin network is branched as the 'YH are coupled to both the {ffi and the oH. If 
weak coupling is assumed throughout then the degenerate oH are labelled T 2, in 
parentheses as they are further away from the aH, and MPX represent the non-
degenerate I3H and the all respectively. In the aromatic rings ofPhe and Tyr there are 
two pairs of symmetry related protons, 3H and 5H, and 2H and 6H, which have the 
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same chemical shift but different couplings with other spins in the aromatic system. 
Such chemical shift equivalence is denoted by AA'. The spin systems for the non-
exchangeable protons in the different amino acid residues are listed in Table 3.4. 
Table 3.4 Side chains (R) of the twenty common amino acids, with three-letter 
and one-letter notation and spin systems for the non-labile protons. The 
structure for Pro includes the backbone CaB and N atoms. 
R 
la 
'W\NV' N - C - C VIMIV\, 
I I II 
H H 0 
Amino acid residue. R is the side chain (see below). Labile protons are shown in bold 
type 
H 
H H H H 
/ C ~ ~
H2C \ 
CH 2 
al H H H H 
N-CH 
/ , CH 2 CH 2 
Pro, P Phe, F Tyr, Y 
A2(T2)MPX AMX + AA'MM'X AMX+AA'XX' 
H H 
H ~ " "
H H-Jrt 
H 5 H 
H CH 2 
Trp, WHis, H 
AMX + A(X)MP + A AMX+AX 
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Table 3.4 (Continued). 
CH 3 , /CH 3 
H CH 3 CH 
Gly, G Ala, A Val, V 
AB A3X A3B3MX 
/H i 
° I 0 CH 3 , / 
XCH 2 CH 
Ser, S Thr, T 
AMX A3MX 
~ ~ ~ ~
0 ~ ~ / 
0 0 ~ ~ / 
N-H 
C C 
I I 
CH 2 CH 2 
Asp,D Asn, N 
AMX AMX 
CH 3, /CH 3 
CH 
I 
CH 2 
Leu,L 
A3B3MPTX 
/H 
S 
I 
CH 2 
Cys, C 
AMX 
i 
0loo.. 0 ~ ~ / 
C 
I 
,H 2 
CH 2 
Glu, E 
AM(PT)X 
/H 
1H3 
CH 3 , /CH 2 
CH 
lie, I 
A3MPT(B3)X 
iH3 
S 
I 
CH2 
I 
CH2 
Met, M 
AM(PT)X+A3 
i 
o N-H 
~ ~ / 
C 
I 
,H 2 
CH 2 
Gin, Q 
AM(PT)X 
N H II / 
H C-N 
,/ , 
N H 
I 
,H 2 
jH2 
CH 2 
39 
Chapter 3 - Introductioll 
o 
A(X)MP 
Figure 3.5 
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COSY and TOCSY connectivity diagrams for the spin systems of non-
labile residues of the common amino acid residues. Cross peaks are 
shown on one side of the diagonal only. Open circles represent those 
cross peaks observed in a COSY experiment, while both filled and open 
circles are observed in TOCSY spectra. 
3.3.2 Correlated Spectroscopy 
The first stage in the assignment of peptide resonances is to identify the 
different spin systems present. This can normally be achived by using two-
dimensional correlated spectroscopy (COSY) (Aue el aI, 1976) and/or total correlated 
spectroscopy (TOCSY or HOHAHA) (Braunschweiler & Ernst, 1983). Spectra 
acquired in these experiments show correlations between coupled spins. Different spin 
systems give rise to characteristic patterns of connectivity (Figure 3.4), and with a 
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knowledge of values of the random coil chemical shifts (Wuthrich, 1986), it is normally 
possible to assign all of the resonances to protons of a particular amino acid type from 
these data. 
3.2.3 Sequential Assignments 
Sequence -specific assignments depend on the observation of through-space 
daN interactions (NOEs) between the a proton of one amino acid and the amide 
proton, or in the case of proline the O-protons, of the next. For L-amino acids, this 
distance varies between approximately 2.20 and 3.55A (Wuthrich, 1986), and so these 
connections can normally be seen for all residues in the peptide. Using this information 
it is possible to identify groups of spin systems corresponding to unique sequences in 
the primary structure of the peptide. Thus sequence specific assignments are obtained 
by matching peptide segments identified from the NOE data to the independently 
detennined amino acid sequence. 
NOEs can be measured using either normal longditudinal cross relaxation 
pathways with one-dimensional (ID) and 2D-NOESY experiments (Jeener et ai, 1983 
~ ~ Bodenhausen et ai, 1984», or via the rotating-frame NOE, called the ROE, in ID 
CAMELSPIN (Bothner-By et ai, 1984) or 2D-ROESY (Bax & Davis, 1985) 
experiments. A major factor affecting the size of the NOE is the tumbling rate of the 
interproton vectors concerned, which is largely determined by the size of the peptide. 
F or linear peptides in non aqueous solvents it is often the case that the tumbling rate is 
such that it is necessary to measure ROEs. 
3.4 Conformation of Antigenic Peptides 
A number of investigations have shown that antigenic peptides have a tendency 
to adopt folded structures in solution (e.g. Dyson et ai, 1985, 1986, 1988a, 1988b ~ ~
Williamson et ai, 1986 ~ ~ Waltho et ai, 1989 ; Tendler, 1990 ; Scanlon et ai, 1992). In 
several cases the ordered region overlaps the defined epitope to which the antibody 
binds (Williamson et ai, 1986 ; Tendler, 1990 ; Scanlon el ai, 1992), suggesting that 
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these structural features my play an important role in antibody recognition of the 
peptide. Indeed it has been suggested that the antigenicity of a peptide is directly 
related to its ability to adopt a stable conformation in solution (Dyson et aI, 1992). 
The choice of solvent for n.m.r. studies is crucial to obtaining a meaningful 
result, as peptides often adopt different structures in different solvents. Most peptides 
are normally found in aqueous environments, and water is therefore widely used. 
However the binding domains of antibodies have been found to contain a high 
proportion of aromatic residues and are therefore less polar (Section 1. 7), 
consequently, a less polar solvent may give a more relevant result. Infact Dyson et al 
(1988b) found that in aqueous solution a 19 residue peptide corresponding to the C-
helix of myohemerythrin adopted a number of rapidly interconverting tum-like 
structures which they termed a nascent helix. These structures were stabilised into a 
regular helical conformation in water/trifluoroethanol mixtures. More recently it was 
shown that the same peptide adopted a helical conformation when bound to the Fab 
fragment of an anti-peptide antibody (Tsang et ai, 1992). Therefore it appears that the 
use of hydrophobic solvents which more closely resemble the environment of the 
antibody binding site, may be valuable in determining the likely conformation of 
peptides complexed to antibody. Further studies of the conformation of antigenic 
peptides, both free and in complexes, may help to provide an understanding of the 
molecular basis of antibody specificity. 
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MATERIALS AND METHODS 
Chapter .J - Methods 
4.1 Reagents 
All reagents were either of analytical grade or, for those described in Section 
4.3.10, molecular biology grade. 
4.1.1 Aldrich Chemical Co., Gillingham, Dorset, U.K. 
Acetic (2H3) acid 
Acetic (2H3) acid sodium salt 
Deuterium oxide (D20) 
Dimethyl formamide (DMF) 
2 ~ - d i m e t h y l l sulphoxide (<4;-dmso) 
Hydrogen peroxide (H20 2) 
Sodium dodecyl sulphate (SDS) 
Tetramethyl silane (TMS) 
3-Trimethylsilyl propane sulphonic acid - sodium salt (TPSS) 
4.1.2 BDH Biochemical Reagents, Poole, Dorset, U.K. 
Acrylamide 
Anhydrous disodium hydrogen orthophosphate 
2-Azino-di-(3-ethyl benzthiazoline-6-sulphonic acid)-diammonium salt (ABTS) 
Bis-acrylamide 
Bromophenol blue 
Chloroform 
Citric acid 
Ethanol (100010) - diluted where appropriate 
Glacial acetic acid 
Glucose 
Glycerol 
Hydrochloric acid (HCI) 
Isopropanol 
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Methanol 
Sodium azide 
Sodium chloride (NaCI) 
Sodium hydroxide (NaOH) 
Sucrose 
Xylene cyanol FF 
4.1.3 Sigma Chemical Co., Poole, Dorset, U.K. 
3-Amino-9-ethyl-carbazole (3-AEC) 
Ammonium persulphate 
Boric acid 
Bovine serum albumin (BSA) 
Casein 
Ethidium bromide 
Ethylene diamine tetra acetic acid (EDTA) 
Light mineral oil 
Ovalbumin 
Papain 
Phenol chloroform isoamyl alcohol 
Polyoxyethylenesorbitan monolaurate (Tween 20) 
Sigmacote™ 
N,N,N',N'-tetramethylethylene diamine (TEMED) 
Thiomersal 
Trihydrous sodium acetate 
Tris-(hydroxymethyl) amino methane (Tris base) 
4.1.4 Pharmacia, Uppsala, Sweden. 
Random oligotide hexamers (N6-hexamers) 
Sephacryl S-200 
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Sepharose 4B-Protein A 
4.1.5 USB Cambridge Bioscience, Cambridge, U.K. 
Sequinase™ DNA sequencing kit 
Urea 
4.1.6 Peptides 
Peptide P(l-20) was the kind gift of Cellteeh Ltd. (Slough, Berks., U.K.) the 
remainder of the peptides described were obtained from the Biopolymer Synthesis and 
Analysis Unit (Department of Biochemistry, QMC, Nottingham, u.K.). Their purity 
was established to be >98% by reversed phase h.p.l.e. 
4.2 ButTers 
All buffers were prepared using de-ionised double distilled water. 
4.2.1 Phosphate ButTered Saline (PBS) - pH 7.3 
PBS tablets were obtained from Oxoid (Basingstoke, Hants). A 150mM 
solution was prepared by dissolving ten tablets in one litre of water. The solution was 
filtered through a What mann 0.2#Lm nitrocellulose membrane (Scientific Lab Supplies, 
Nottingham, U.K.). 
4.2.2 PBSA - pH 7.3 
Where a preservative was necessary, sodium azide was added to PBS buffer to 
give a final concentration of 0.02% (w/v). 
4.2.3 PBS/fween - pH 7.3 
Tween 20 was added to PBS buffer to give a final concentration of 0.1% (v/v). 
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4.2.4 PBSA - pH 8.0 
Phosphate buffer at pH 8.0 was prepared by taking one litre of PBSA prepared 
as described above, and adjusting the pH to 8.0 with 1M NaOH. 
4.2.5 Papain Activation Buffer - pH 6.5 
The activation buffer was prepared by dissolving one PBS tablet and 74.4mg of 
EDT A in SOml of water. Subsequently, mercaptoethanol ( 7 0 ~ 1 ) ) was added and the pH 
adjusted to 6.5 with O.IM Hel. The volume was made up to 100ml with water. 
4.2.6 Digestion Buffer - pH 6.5 
The digestion buffer was prepared by dissolving one PBS tablet and 74.4mg of 
EDT A in 90ml of water. The pH was adjusted to 6.5 with 0.1 M Hel and the volume 
made up to 100ml with water. 
4.2.7 Casein Buffer - pH 7.3 
Casein (1 OOmg) was dissolved in one litre of PBS by stirring overnight at room 
temperature. If the buffer was to be kept for more than 24h thiomersal was added to a 
final concentration of 0.005% (w/v) . 
4.2.8 Sodium Acetate (Stock Solution) 
For aIM stock solution, trihydrous sodium acetate (13. 608g) was dissolved in 
80m I of water and the solution adjusted to the desired pH (usually 5.0) by the 
dropwise addition of glacial acetic acid. This solution was made up to lOOml and 
diluted to the required concentration prior to use. 
4.2.9 TrislHCI (Stock Solution) 
For aIM stock solution T ris base (121.14g) was dissolved in 900ml of water. 
The pH of the solution was adjusted to the desired value by addition of 2M HCI and 
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the solution was made up to one litre with water. Prior to use the stock solution was 
diluted to the required concentration. 
4.2.10 SDS Sample Loading Buffer 
Proteins were applied to SDS gels in non reducing sample buffer. This was 
prepared as follows: 
Component (ml) 
O.SM TrislHCI (pH 6.8) 1.0 
glycerol 0.8 
10% (w/v) SDS 1.6 
0.05% bromophenol blue 0.2 
water 4.4 
total 8.0 
4.2.11 Deuteroacetate buffer - pH 4.4 
A stock solution ofO.IM sodium acetate (A) was prepared by dissolving 8Smg 
of acetic-(2H3)-acid sodium salt in lOOml of 90% H20/10% D20 or °2° alone. A 
stock solution of 2M acetic acid (B) was prepared by mixing O.Sml acetic-(2H3)-acid 
with 4.44ml of 90% H20/10% °2° or °2°. 1.88ml (A) plus I S O ~ I I (B) gave a 
solution of deuteroacetate buffer in either 90% H20/IO% 020 or 020 at pH 4.4. 
4.2.12 Citrate-Phosphate Buffer - pH 4.0 
Citric acid (4.S3g) and anhydrous disodium hydrogen phosphate (4.06g) were 
dissolved in water (4S0ml). The pH was adjusted to 4.0 by dropwise addition of 1M 
Hel and the volume made up to SOOml with water. The buffer was stored at 4°C for 
up to one month. 
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4.2.13 Tris-Boric Acid-EDTA (TBE) - pH 8.0 
A 5 x stock solution ofTBE was prepared by dissolving Tris base (54g), boric 
acid (27.5g) and EDTA (3.7g) in water (500ml). The buffer was sterilised by 
autoclaving and diluted prior to use. 
4.2.14 DNA Sample Loading Buffer 
A 5 x stock solution of the DNA sample loading buffer was prepared by 
dissolving bromophenol blue (0.25g) and xylene cyanol FF (0.25g) in 40% (w/v) 
sucrose solution (1 00ml). 
4.2.15 Solution I 
Tris base (3.02g) and EDT A (0.372g) were dissolved in water (80ml) and the 
pH adjusted to 8.0 by the dropwise addition of O.lM He\. Finally, glucose (0.45g) 
was added and the solution made up to 100ml with water. 
4.2.16 Solution II 
Solution II was prepared freshly by dissolving SDS (1 g) in a NaOH solution 
(0.2M, 100ml) 
4.2.17 Solution III 
Potassium acetate (29.45g) was dissolved in water (60ml), glacial acetic acid 
(l1.5ml) added and the volume made up to to 100ml with water. 
4.2.18 LB-Medium (Luria-Bertaoi Medium) 
The medium was prepared by dissolving bacto-tryptone ( 109, Difco, E. 
Molesey, Surrey, u.K.), bacto-yeast extract (5g, Difco) and NaCI (lOg) in 950ml of 
water. The pH was adjusted to 7.0 by dropwise addition of 5M NaOH, and the 
volume made up to 1 litre. The medium was sterilised by autoclaving. 
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4.3 Methods 
4.3.1 Enzyme-Linked Immunosorbent Assay: Epitope Mapping Studies With 
Synthetic Peptides 
The minimum sequence required for binding of monoclonal antibody C595 was 
determined using a series of fifteen overlapping peptide heptamers tethered at their C-
termini to polypropylene pin supports. The peptides were related in sequence to the 
twenty amino acid tandem repeat of the MUCI core protein (Gendler et ai, 1988) 
(Table 4.1). 
Table 4.1 Sequence of the MUCI tandem repeat, and synthetic peptide heptamers 
used in ELISA. 
1 20 
GSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTR 
1 PPAHGVT 
2 PAHGVTS 
3 AHGVTSA 
4 HGVTSAP 
5 GVTSAPD 
6 VTSAPDT 
7 TSAPDTR 
8 SAPDTRP 
9 APDTRPA 
10 PDTRPAP 
II DTRPAPG 
12 TRPAPGS 
13 RPAPGS T 
14 PAPGSTA 
15 APGSTAP 
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Each peptide overlapped by six amino acids, so that the heptamers covered a 
region starting at position 12 of one repeat and continuing through to position 12 of 
the next. Thus the peptides scanned through the previously identified antibody binding 
domain of the MUC 1 core protein (Xing et ai, 1990 ; Briggs et ai, 1991). Antibody 
binding to the pins was assessed in an enzyme linked immunosorbent assay (ELISA), 
as originally described by Geysen et al (1984). ELISAs were performed in 
quadruplicate on Falcon 96-well microtitre plates (Becton Dickinson, CA, USA). The 
pins were arranged in such a way that during each stage of the assay they could be 
immersed in separate wells on the plate containing either antibody or reagent (Figure 
4.1). 
I ~ ~ n n n n U n - H - - ~ ~I Hultipin Supporl 
o 000000000000 0 
000000000000 
000000000000 --+--- 96 Well Microtitre Plate Stgle 
000000000000 
000000000000 
000000000000 
000000000000 
o 000000000000 0 
Figure 4.1 Configuration of epitope mapping pins for ELISA performed on 96-
well microtitre plates. 
The irnmobilised peptides were incubated for lh in a solution of 1% (w/v) 
ovalbumin and 1% (w/v) BSA in PBSlTween containing 0.02% (w/v) sodium azide, in 
order to block non-specific adsorption sites. The pins were then incubated overnight at 
4°C in 175Jlllwell of C595 (lOmglml) in PBSA. After washing (4 x 10rnin) in 
PBS/Tween at room temperature with agitation, the pins were incubated for 1 h at 
room temperature in 150Jlllwell of horse radish peroxidase (HRP) conjugated rabbit-
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anti-mouse immunoglobulins (DAKO Ltd., High Wycombe, Bucks.) diluted I :500 in 
PBS containing 1% (w/v) BSA. The pins were then washed (4 x 10min) in PBSrrween 
at room temperature with agitation, and incubated in the dark with 150"Vwell of 
0.05% (w/v) ABTS in citrate phosphate buffer pH 4.0, containing 30ml hydrogen 
peroxide (120 vol) per lOOm1 ofbuft'er. Incubation was stopped by removing the pins 
from the wells when sufficient when sufficient colour had developed. The absorbance 
in the wells at 405nrn was read using an Anthos Labtec Instruments 2001 plate reader. 
Positive and negative controls for the assay were included in the block of pins 
in the form of two tetrapeptides, PLAQ and GLAQ. These were tested simultaneously 
for reactivity with an anti-PLAQ antibody (Cambridge Research Biochemicals, 
Northwich, Cheshire, U.K.) using the same protocol as described above. 
4.3.2 Inhibition Assays 
The ability of peptides (Table 4.2) to block the binding of intact mucin to anti-
MUC 1 antibodies was measured by their competitive activity in a two-site 
immunoradiometric (sandwich) assay (Price et 01, 1990b). 
Table 4.2 Sequences of peptides used in inhibition assays. 
Peptide Sequence 
P(1-20) PDTRPAPGSTAPPAHGVTSA 
P(1-11) PDTRPAPGSTA 
P(7-20) GSTAPPAHGVTSA 
D-peptide APDTRPAPG 
E-peptide APETRPAPG 
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The capture antibody (1 OJlI at 10Jlglml in PBSA) or PBSA alone was adsorbed 
onto the walls of Terasaki Microtest plates (Becton Dickinson) for ISh at 4°C. The 
wells were aspirated and washed four times with casein buffer. then incubated for Ih at 
25°C in casein buffer to block non-specific binding. Portions (5J11) of the peptides at 
various concentrations (I mglml - lOJlglml) plus casein buffer (5 JlI) were added to the 
wells and the plates incubated for 2h at 37°C. The plates were aspirated and the wells 
washed four times with casein buffer. Portions (5J11) of the peptide solutions at the 
same concentrations as in the previous incubation plus purified mucin (5J11 in PBSA, 
approx IOJlglmI as estimated from antigen-antibody titrations (Price et ai, 1990b» 
were added to the wells and the plates incubated for a further 30min at 4°C. The 
plates were aspirated and washed four times with casein buffer. 12SI-labelled NCRC-
II antibody (as the radioactive tracer to detect mucin captured on the solid phase) was 
added to the wells at IOJlI per well (corresponding to 1.5 x 105 c.p.m). After 
incubation for 1 h at 20°C, the wells were aspirated and the plates washed six times 
with casein buffer. The wells were separated with a band saw and the radioactivity in 
each well was determined using an LKB -y-radiation counter. Tests were performed in 
triplicate and the mean ± s.d. was recorded. 
4.3.3 Radio-Immunoassay 
The capacity of C595 antibody and its Fab fragments to bind to urinary mucin 
was measured using an indirect radioisotopic antiglobulin assay (price et ai, 1990b). 
Purified urinaJY mucin (IOJlI at approx IOJlglml) was added to the wells of Terasaki 
microtest plates and air dried overnight at 4°C. Non specific adsorption sites were 
blocked by incubation with casein buffer for lh at 25°C. The wells were aspirated and 
then incubated with either whole C595 antibody, its Fab fragments (IOJll at IOJlglml in 
casein buffer in each case) or cell free supernatant (P3NSO. IOJlI) for lh at 25°C. The 
wells were aspirated and washed four times with casein buffer before being incubated 
with 125I-labelled F(ab'h fragments of rabbit anti-mouse immunoglobulins (DAKO) at 
105 c.p.m.lIOJll per well (lh at 25°C). After washing six times with casein buffer the 
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wells were separated with a band saw and the radioactivity in each well was 
determined using an LKB -v-radiation counter. Tests were performed in quadruplicate 
and the mean ± S.d. was recorded. 
4.3.4 Papain Digestion or C595 
C595 antibody, purified from tissue culture supernatants (Price et ai, 1991) 
was digested using a column of immobilised papain. This was prepared by mixing 
excess papain with Affi-Gel 10 (ImJ, BioRad, Herts, U.K.). The papain was activated 
with phosphate buffer (150mM) at pH 6.5 containing mercaptoethanol (1 OmM) and 
EDT A (2mM). Mercaptoethanol was removed from the column with phosphate buffer 
(1Ornl, 150mM) at pH 6.5 containing EDTA (2mM). Antibody C595 (5.2Smg) in 
digestion buffer was cycled through the column at 10mVh. Aliquots (I OJll) were 
removed from the column over a period of 24h and the extent of antibody digestion 
determined by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) and sensitive silver staining. The optimum digestion time was taken to be the 
point at which whole antibody could no longer be detected on the SDS-P AGE gel 
using the silver stain. F ab preparations were undertaken as described above except 
that the proteolysis was allowed to proceed for ISh after which time the crude digest 
was collected, the residue washed from the column with digestion buffer (2ml), and the 
fragments purified. 
4.3.5 Purification or Fab Fragments 
Fab fragments of C595 were purified by passing the digest sequentially through 
a Sepharose 4B-protein A column and a Sephacryl S-200 gel exclusion column at 
50ml/h in PBSA at pH S.D. Before purification the proteolytic digest was dialysed 
overnight into PBSA at pH S.O in order to improve binding of the Fc containing 
antibody fragments to the protein A. Fractions were collected and assayed for protein 
content by measuring their absorbance at 2S0nm on a Pye Unicam SPS-400 
UVNisible spectrophotometer. Fab containing fractions were pooled, dialysed into 
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PBSA at pH 7.3 concentrated, and analysed by Western blotting. The final Fab 
concentration was determined using E 1%(280nm) = 15.3 (Hudson & Hay, 1989). 
4.3.6 SOS-Polyacrylamide Gel Electrophoresis 
SDS-PAGE (Laernm1i, 1970) gels were run on a Pharmacia Phastsystem 
apparatus according to the manufacturers instructions. Protein samples were diluted 
with an equal volume of non-reducing SOS loading buffer and loaded onto 12.5% 
polyacrylamide gels. After electrophoresis, the gels were developed in the Phastsystem 
development unit using a sensitive silver stain (Oakley el ai, 1980) according to the 
manufacturers instructions. The molecular weights of proteins were estimated by 
comparison of their migration with that of the following standards obtained from BRL, 
Uxbridge, Middlesex. 
Protein Molecular Weight 
myosin (H-chain) 200,000 
phosphorylase B 97,000 
bovine serum albumin 68,000 
ovalbumin 43,000 
carbonic anhydrase 29,000 
~ - I a c t o g l o b u l i n n 18,400 
lysosyme 14,300 
4.3.7 Western Blotting 
Western blots were performed on a Pharmacia Phastsystem using the supplied 
semi-dry electrophoretic transfer apparatus according to the manufacturers 
instructions. After transfer the nitrocellulose membranes (Scientific Lab Supplies) 
were blocked with casein buffer for 2h at room temperature then incubated for with 
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horse radish peroxidase conjugated sheep-anti-mouse-kappa-Iight-chain antibodies 
(OAKO, diluted 111000 in casein buffer) for 1 h at room temperature. The substrate 
was prepared by mixing 3-AEC (I.6ml of a stock solution at a concentration of 0.4% 
(w/v) in DMF) with sodium acetate buffer (50mM, 38m1 at pH 5.0) and PBSrrween 
(2m1). Hydrogen peroxide (120 vol., 1 0 ~ 1 ) ) was added to the substrate buffer 
immediately prior to development. 
4.3.8 Fluorescence Quenching 
Fluorescence measurements were carried out at room temperature on a Perkin 
Elmer LSS luminescence spectrophotometer. The optimum excitation and emission 
wavelengths was determined by recording excitation and emission spectra of the Fab 
over the range 260-400nm. The excitation wavelength used was 282nm with a slit 
bandwidth of 2.Snm, and the fluorescence intensity was recorded at an emission 
wavelength of 362nm with a lOnm bandwidth. The concentration of Fab used in the 
quenching experiments was 3 x 10-7 M. The maximal quenching value was determined 
using a 30-40 molar excess of peptide P(l-20) to ensure complete saturation of the 
binding sites. No correction for peptide concentration was required as P( 1-20) 
contains no chromophoric group that absorbs light in the wavelength range 280-
380nm. Titrations were performed by adding I ~ l l aliquots of a I mM solution of the 
peptide to Imi of a solution of the Fab in the appropriate buffer. Corrections for 
dilution were applied by performing blank titration in which 1 ~ I I a1iquots of buffer were 
added to Iml of a similar solution of Fab, and these data were subtracted from the 
corresponding peptide titration values. 
4.3.9 N.M.R. Spectroscopy 
For experiments undertaken in ~ - d m s o , , samples contained approximately 
4mM peptide and 0.09mM tetramethylsilane (tms). IH-n.m.r. experiments were 
undertaken at 400MHz, 500MHz and 600MHz on Bruker AM400, AMSOO and 
AMX600 spectrometers respectively. Over the range of approximately 2-10mM, no 
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concentration dependent change in the chemical shift of the resonances was observed 
for any of the peptides. Chemical shift values (cS), accurate to 0.01 ppm are reported 
relative to the tms resonance (cS = 0.00). In order to prepare the D-and E-peptides in 
their protonated states, the peptides (2mg) were dissolved in water (2ml) and the pH 
adjusted to 2.0 with Hel (O.lM). After lyophilisation, the peptides were dissolved in 
~ - d m s o o (O.5ml). 
For the aqueous experiments P(1-20) (3.Omg) was dissolved in deuteroacetate 
buffer (0.54ml) in 9()01o H20/1O% D20 or °20 alone and a trace amount of 3-
(trimethylsilyl)-l-propane-suiphonic acid sodium salt (TPSS) was added as an internal 
reference. For experiments performed in D20 the peptide was lyophilised twice from 
°20 to remove the exchangeable protons then redissolved in °20 deuteroacetate 
buffer prior to investigation by n.m.r. spectroscopy. For the aqueous experiments, 
chemical shift values are reported relative the TPSS resonance (cS = 0.00). 
4.3.9.1 One-Dimensional Spectra 
Experimental parameters used for the acquisition of 1 D spectra at 400MHz are 
summarised in Table 4.3. Experiments undertaken at higher field strengths were 
recorded with proportionately larger sweep widths. 
Table 4.3 Experimental parameters used in 10 n.m.r. experiments at 400MHz. 
Sweepwidtb 
(Hz) 
5000 
Size before 
zero filling 
16k 
Size after 
zero filling 
32k 
Resolution 
(Hz/pt) 
0.305 
For the temperature study, spectra were recorded between 293K and 3] 8K 
with 5K increments. A twenty minute period was allowed for temperature 
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equilibration between each of the experiments. The residual water signal was 
suppressed by presaturation at all times except during the acquisition period. In cases 
where signal overlap made it impossible to assign the amide proton resonances from 
the 10 spectrum alone, HOHAHA spectra were acquired at different temperatures. 
4.3.9.2 Two-Dimensional Spectra 
20 experiments were typically recorded at 303K into 512 x 2k files. A 
summary of the acquisition parameters used in the different experiments is presented in 
Table 4.4. 
Table 4.4 Summary of experimental parameters used in 20 n.m.r. experiments at 
400MHz. 
Parameten COSY HOHAHA NOESY ROESY 
Sweep width in F2(Hz)3 5000 5000 5000 5000 
Sweep width in FI(Hz)3 2500 2500 2500 2500 
Matrix size (F 1 x F2) 
before zero-filling 512xlk 512x2k 512x2k 512x2k 
Matrix size (F 1 x F2) after 
zero-filling lkx2k lkx2k lkx2k lkx2k 
Mixing times (ms) 40-120 100-600 100-200 
Window functions for 
20FT (FIIF2)b SIS SIS SIS SIS 
Shifts of window function 
in fractions of r (FIIF2) 112 112 112 112 
a The sweep widths quoted are for experiments performed at 400MHz. Spectra 
acquired at higher field strengths had proportionately higher sweep widths. 
b S stands for sine-bell squared. 
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The 2D experiments were performed in phase sensitive mode using time 
proportional phase incrementation (TPPI). For the HOHAHA experiment 
(Braunschweiler & Ernst, 1983) isotropic mixing was achieved using a MLEV 17 pulse 
sequence. In the ROESY experiments (Bax & Davis. 1985) a field strength of I-2kHz 
was used for spin locking. Spin-locking was achieved either by using a DANTE pulse 
sequence at 400MHz or a continuous wave (CW) pulse at 500MHz and 600MHz. 
ROESY and NOESY (Bodenhausen et ai, 1984) spectra were acquired at least twice 
using either different transmitter frequencies or frequency offsets to ensure that amide 
to amide cross peaks did not arise as a result of incoherent Hartmann-Hahn 
magnetisation transfer. 
4.3.10 Molecular Biology 
4.3.10.1- RNA Extraction 
595/102 (NCRC-48) hybridoma ceUs (1 x 107) were harvested by 
centrifugation (3000g for 5 min) on a Microcentaur microcentrifuge. The supernatant 
was removed by gentle aspiration, and the ceUular pellet vortexed briefly before 
resuspension in RNAzolTM B solution (lml, Biogenesis Ltd., Bournemouth, u.K.). 
The RNA was solubilised by passing the lysate a few times through a pipette. 
Chloroform (O.lmI) was added to the homogenate and the sample vortexed 
vigourously for 15s before being left to stand on ice for 5min. The resulting 
suspension was separated by centrifugation (3,OOOg for 15min at 4°C). Addition of 
chloroform separates the homogenate into two phases. The lower blue 
phenol/chloroform phase and the aqueous upper phase. RNA is retained exclusively in 
the aqueous phase whereas the DNA and proteins remain in the interphase or the 
organic layer. 
The aqueous phase was gently removed and transferred to a fresh Eppendorf 
tube and an equal volume of isopropanol added. The sample was left on ice for 15min 
to allow the RNA to precipitate. Centrifugation (3,OOOg for 5min at 4°C) recovered 
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the RNA as a yellow/white pellet. The supernatant was removed by aspiration and the 
pellet washed twice by addition of 75% ethanol (1 ml), vortexing (15s) and subsequent 
centrifugation (1750g for 8min at 4°C). After washing the supernatant was removed 
by aspiration, and the pellet air-dried for 15-20min. The pellet was resuspended in 
SOIlI of sterile distilled water and stored at -20°C. 
4.3.10.2 Quantitation of Nucleic Acids 
The concentration of nucleic acid was determined spectrophotometrically. 
Samples (51l1) were diluted to lml in water and optical densities recorded at 260nm 
and 280nm using quartz cuvettes on a Pye Unicam SP8-400 UV Nisible 
spectrophotometer. The quantity of DNA or RNA was calculated using the following 
equations (Sambrook et ai, 1989) 
[DNA, Ilg/ml] = absorbance (260nm) x 50 
[RNA, Ilg/ml] = absorbance (260nm) x 40 
The purity of the samples was assessed assuming that the A(260nm)/A(280nm) 
for pure double stranded DNA = 1.8 and for RNA = 2.0 (Sambrook et ai, 1989). 
4.3.10.3 Reverse Transcription 
RNA extracted from the 595/ I 02 hybridoma cells was quantitated 
spectrophotometrically. Total RNA (lOllg) was resuspended in sterile distilled water 
(lllll) in a O.Sml Eppendorftube. To this was added 10 x PCR Buffer (21l1, NBL, 
Cramlington, Northumberland, U.K.), 5mM dNTPs (4 Ill), N6-hexamers (21l1) and 
Superscript™ RNase H- Reverse Transcriptase (RT, I Ill, Gibco BRL, Uxbridge, 
Middlesex, u.K.). The mixture was SUbjected to the following temperature cycle on a 
Pharmacia AT AQ Gene Controller PCR block. 
tOmin @ 25°C - annealing of random primers 
60min @ 37°C - reverse transcription 
10min @ 95°C - denaturation of reverse transcriptase 
59 
Chapter -I - Methods 
After the final incubation, the tube was transferred immediately to ice. cDNA 
generated in this way was used directly for the PCR reactions without further 
purification. Negative controls for reverse transcription were set up in the form of 
tubes to which an extra 1 J.d of water was added in place of the R T enzyme. 
4.3.10.4 Amplification of DNA 
To cDNA (1 J.lI) or the negative control (1 J.l1) generated as described above in a 
O.Sml Eppendorf tube was added 5mM dNTPs (4J.lI), 50pM each of the appropriate 
primers (O.SJ.lI from a lOOpMlJ.l1 stock), 10 x PCR buffer (1OJ.l1) and sterile distilled 
water (80J.l1). The following primers were used for amplification of the heavy- and 
light-chain DNA respectively. 
Heavy chain variable region 
VHI FOR-2S'-TGAGGAGACGGTGACCGTGGTCCCTTGGCCCC-3' 
VHl BACK5'-AGGTCCAGCTGCAGGAGTCTGG-3' 
Kappa chain 
3'-PRIMER S'-GCGCCGTCTAGAATT AACACTCATTCCTGTTGAA-3' 
5'-PRIMER 5'-CCAGTTCCGAGCTCGTTGTGACTCAGGAATCT -3' 
Finally, the AmphitaqTM DNA polymerase enzyme (1 JlI, Promega, 
Southampton, Bants, U.K.) was added using a positive displacement pipette. The 
mixture was overlaid with light mineral oil (SOJlI) and subjected to 30 cycles of the 
following temperature profile. 
4Ss @ 94°C - denaturation of double stranded DNA 
4Ss @ S6°C - annealing of primers to DNA template 
90s @ 72°C - strand elongation. 
After completion of the temperature cycles, the tubes were transferred to ice, 
analysed by agarose gel electrophoresis and then stored at -20°C. 
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4.3.10.5 Agarose Gel Electrophoresis 
Agarose gels (1-2%) were prepared by dissolving powdered NuSieve™ 
agarose (F1owgen. Sittingbourne, Kent, U.K.) in the required volume of TBE buffer 
using either a water bath at 95°C or by heating in a microwave oven. Once completely 
dissolved, the agarose solution was allowed to cool to approximately 50-55°C and 
then poured into the appropriate electrophoresis tank and the comb inserted. Ethidium 
bromide (0.2 mglml) was incorporated into the gel prior to pouring. Once set, the 
comb and gel forming plates were removed and the gel was placed In an 
electrophoresis chamber (pharmacia) and covered with TBE buffer pH 8.0. 
Prior to loading samples were diluted 4: 1 with DNA loading buffer. 
Electrophoresis was performed at a constant voltage of between 100-150 V and 
continued until the faster dye front (bromophenol blue) had migrated almost the full 
length of the gel. DNA was visualised by illumination of the gel using a Spectroline 
TM-312A ultra violet transilluminator and photographs recorded using a Polaroid DS-
34 direct screen instant camera. Molecular weight markers were non-methylated 
bacteriophage </>X174 DNA digested with restriction endonuclease Hae III (NBL, 
Cramlington. Northumberland, U.K.). 
4.3.10.6 Ligation of peR Fragments 
Ligations were performed using a T A CloningTM Kit (Invitrogen, San Diego, 
CA, U.S.A.) according to the manufacturers instructions. PCR fragments were ligated 
into the PCR TM II vector directly after amplification without further purification. A 
rough estimate of the amount of DNA present after amplification was obtained by 
visualising the PCR product on a 2% agarose gel. Ligations were set up between 1: I 
to 1:3 molar ratio of PCRTM II vector to PCR product using 50 ng of vector per 
reaction. 
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4.3.10.7 TA CloningTM Transformation 
Transformation of competent E.coli supplied with the T A Cloning Kit was 
undertaken according to the manufacturers instructions. After the transformation 
reactions were complete, aliquots (25,.11 or l00f.11) were spread onto agar plates 
containing kanamycin (50f.1g/ml) and X-Gal (Boehringer-Mannheim, Lewes, E.Sussex, 
U.K. ; 50fll from a 2Omg/ml stock solution), prepared as described in Section 4.3.10.8. 
4.3.10.8 Preparation of Agar Plates 
Agar plates were prepared by adding bacto-agar (ISg, Difco) to one litre of L-
Broth according to the protocol described in Sambrook el al (1989). Plates used for 
selection of transformed E.coli were coated with X-Gal (SOfll from a 20mg/ml stock 
solution) and allowed to air dry prior to spreading the bacterial culture. 
4.3.10.9 Bacterial Culture 
General culture techniques were taken from Sambrook et al ( 1989). 
Transformed cells were selected from white colonies on the agar plates and transfrred 
to LB-Medium (Sml) using a sterile needle. The cultures were grown overnight on a 
gyratory shaker (200rpm, 37°C). The plasmid was purified from the bacterial culture 
using a modified alkaline lysis method. 
4.3.10.10 Minipreparation of Plasmid DNA 
Plasmid DNA isolated using this method was routinely used for electrophoretic 
analysis, restriction endonuclease digestion and as a template in DNA sequencing 
reactions. The procedure is a modification of the rapid alkaline lysis method of Ish-
Horowicz & Burke (1981). Samples (1.5ml) were removed from overnight cultures 
(5ml) of bacteria and centrifuged (3,OOOg for Smin) in a MSE Centaur centrifuge. The 
pellet was resuspended in l00fll of Solution I. To this suspension was added 200fli of 
Solution II and the tube agitated gently to ensure complete lysis of the bacteria. To 
the lysed solution was added 150fll of Solution III and the tube shaken vigourously for 
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5s before incubation on ice (5 min). Bacterial debris was pelleted by centrifugation 
(3,OOOg for 5min) and the clear supernatant removed to a clean tube. The nucleic acid 
was purified by the addition of an equal volume of phenoVchloroform. The mixture 
was vortexed vigourously, and the two layers separated by centrifugation (3,OOOg for 
5min) on a microcentrifuge. The upper layer containing the plasmid was carefully 
removed to a fresh tube. Nucleic acid was precipitated by addition of 1000/0 ethanol 
(720,11) and pelleted by centrifugation (13,000 rpm for 5min). The pellet of crude 
nucleic acid was washed once with 70010 ethanol, air dried, and resuspended in sterile 
distilled water (50J.l1). 
4.3.10.11 Restriction Endonuclease Digestion 
Purified plasmid DNA was tested for incorporation of the appropriate PCR 
fragment by digestion with EcoR I (Cambridge Bioscience, Cambridge, u.K.) in lOx 
High Buffer (Cambridge Bioscience). The plasmid (lJ.l1 from stock obtained by 
minipreparation) was digested in a volume of lOJ.lI for 2h at 37°C. 
4.3.10.12 DNA Sequencing Reactions 
Di-deoxy sequencing reactions (Sanger et ai, 1977) were performed using a 
SequinaseTli DNA sequencing kit according to the manufacturers instructions. 
Purified plasmid DNA (5J.lg) was dissolved in sterile distilled water (30J.lI). The 
plasmid was denatured by addition of 2M NaOH (SJ.lI) followed by incubation at room 
temperature for Smin. The DNA was then precipitated by the addition of ice cold 
100010 ethanol (l20J.lI) and 1M sodium acetate buffer pH S.O (l5J.lI). After incubation 
for a further 5min at room temperature the plasmid was pelleted by centrifugation 
(3,OOOg for lOmin) on a microcentrifuge. The supernatant was decanted and the tube 
inverted to allow the DNA precipitate to air dry. The plasmid contains a priming 
sequence at each end of the cloning site. These primers, T7 and Sp6 (NBL) were used 
for the reactions. After the sequencing reactions were complete, stop solution (5J.l1) 
was added to each of the tubes and mixed by pipetting. The samples were either 
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analysed immediately by polyacrylamide gel electrophoresis or stored for later analysis 
at -20°C. 
4.3.10.13 DNA Sequencing Gels 
DNA sequencing gels were cast between the plates of a Bio-Rad SequiGen™ 
sequencing apparatus with an integral plate/chamber (IPC). Prior to casting the gel, 
the glass plates were extensively cleaned with soap and water, tap water, distilled 
water and finally ethanol and allowed to air dry. The removable plate of the IPC was 
then coated with Sigmacote™ in order to facilitate the subsequent removal of the gel 
from the plate. The solution was spread evenly over the plate and allowed to dry. The 
plates were then assembled according to the manufacturers instructions using O.4mm 
spacers. Acrylamide for use in the sequencing apparatus was prepared freshly as 
required and contained acrylamide (S.7% w/v) bis-acrylamide (0.3% w/v) and urea 
(48% w/v) in 1 x TBE. Ammonium persulphate (2S% w/v, 100J.lI) and TEMED 
(100J.l1) were added to the acrylamide mix (20 mI). The solutions were mixed by 
swirling and then poured briskly into the casting tray to seal the bottom of the gel. 
Once the plug had set, 85 mI of the acrylamide mix was used to fonn the gel itself 
The acrylamide was de-gassed using a Buchner flask for Smin before addition of 
ammonium persulphate (10010 w/v, O.SmI) and TEMED (2SJ.lI). The solutions were 
mixed thouroughly, transferred into a SOmI syringe and injected carefully between the 
glass plates which were inclined at an angle of approximately 4S0 to the horizontal to 
facilitate pouring. Immediately after the gel was poured a flat O.4mm spacer was 
placed into the acrylamide on the gel top such that it intruded into the gel by 
approximately 10mm. This allowed the fonnation of a flat gel surface essential to the 
effective use of the sharks tooth comb during electrophoresis. The gel was then laid 
flat and allowed to polymerise at room temperature for 3h. Once the gel had set, the 
plates were assembled in the electrophoresis apparatus according to the manufacturers 
instructions. The buffer chambers were filled with 1 x TBE and the gel pre-
electrophorised at 2,000 V to heat it to the required operating temperature (50°C). 
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The sharks tooth comb was then inserted so that the tips protruded into the gel by 
approximately 2 mm. Sequencing reaction mixtures were heated to 75°C for 5min 
prior to loading to denature any secondary structure and loaded into the wells 
(2J.lVwell) in the order G, A. T, C. Electrophoresis of the samples was then allowed to 
proceed at a constant power of 55 W for 2-6h. After electrophoresis was complete, 
combs were removed and the IPC was carefully separated from the remaining plate and 
gel. The gel was then immersed in a fixative solution containing glacial acetic acid 
(10010 v/v) and methanol (10010 v/v) for 15min. The gel was transferred onto a large 
sheet of What mann 3MM filter paper (Scientific Lab Supplies) and dried on a vacuum 
gel drier (85°C for 75min) prior to autoradiography. 
4.3.10.14 Autoradiography 
Dried gels containing 35S nidioactivity were placed in contact with pre-flashed 
Kodak XAR-5 X-ray film (Sigma Chemical Co.). The gel and film were sealed in a 
light-tight aluminium autoradiography cassette (Sigma Chemical Co.) and exposed for 
varying lengths of time. Autoradiographs were developed in Polycon™ developer 
(KJP, Nottingham, u.K.) (diluted 1 :4) for 15min, washed briefly in water and fixed in 
PerfixTM fixer (KJP) (diluted 1 :4). The autoradiographs were washed in tap water and 
air dried. 
4.3.10.15 Reading of Sequencing Gels 
Autoradiographs of sequencing gels were read manually. The gels were read 
independently by at least two people and then loaded onto the Daresbury Seqnet 
computer. Sequences were aligned using the program Gap (Needleman & Wunsch, 
1970) and any discrepancies checked against the original autoradiograph. Similar 
DNA sequences were identified using the program FAST A (pearson & Lipman, 1988). 
After translation, similar protein sequences contained in the Swissprot database were 
identified with the program PF AST A (pearson & Lipman, 1988). 
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CHAPTER FIVE 
BINDING STUDIES 
Chapter 5 - Results 
5.1 Introduction 
In order to characterise the molecular basis of antibody-antigen interactions, it 
is necessary to precisely define the epitope with which the antibody reacts. A number 
of murine monoclonal antibodies for which MUC 1 is the target antigen have been 
found to define epitopes within the tandem repeat of the protein core. The antibody 
C595, raised against affinity purified urinary mucin (Price et ai, 1990a), has been tested 
for reactivity with a series of synthetic peptides in an attempt to accurately map the 
precise determinant with which it reacts. 
5.2 Epitope mapping with synthetic peptide heptamers 
Antibody binding to the immobilised peptides was detected in the form of 
colour development in the corresponding well of a micro titre plate. The results of the 
ELISAs for C595 are presented graphically in Figure 5.1 . 
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F i ~ u r e e 5.1 Antibody C595 binding to synthetic peptides based on the tandem 
repeat sequence of the MUCI protein core. 
C595 bound to four sequential peptides, from PDTRP AP to RP APGST. The 
common sequence shared by these peptides is Arg-Pro-AJa-Pro (Figure 5.2). This 
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represents the minimum structure required for binding of the antibody. Hence C595 
reacts with the tandem repeat domain in the protein core ofMUCl. 
Figure 5.2 
PDT 
DT 
T 
G 
GS 
GST 
Minimum structure required for binding of monoclonal antibody CS9S. 
5.3 Inhibition Assays 
The inhibition of binding of MUC 1, affinity purified from urine (price et aI, 
1 990b ), to the antibody C595 by peptides P(1-II), P(l-20) and PC7-20) is presented 
graphically in Figure 5.3. 
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Figure 5.3 Inhibition of MUC I binding to the monoclonal antibody C595 by 
synthetic peptides in solution. 
Peptides PC 1-11) and PC 1-20) showed significant inhibition of antigen binding 
compared to P(7-20), which failed to affect this binding. These results clearly 
demonstrate that pep tides containing the identified epitope for this antibody, Arg-Pro-
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Ala-Pro, can inhibit the binding of the anti-mucin monoclonal antibody C595 to the 
intact urinary mucin. 
5.3 Discussion 
The epitope mapping studies clearly show that the monoclonal antibody C595 
reacts with a determinant Arg-Pro-Ala-Pro which is contained within the tandem 
repeat domain of the protein core of MUC 1. Furthermore, the inhibition assays 
demonstrate that peptides based on the tandem repeat sequence and the intact MUCI 
molecules compete for the same binding site on this antibody. Therefore, 
investigations of the conformations adopted by these peptides in solution may provide 
an insight into the structural requirements for antibody binding to the mucin. 
68 
CHAPTER SIX 
CONFORMATIONAL STUDIES OF P(1-20) 
Chapter 6 - Results 
detennine whether a salt bridge between the side chains of the aspartic acid and 
arginine residues plays a role in the stabilisation of the observed type-I IJ-turn in P( 1-
20) in d6-dmso, the exchange characteristics of the low field resonances have been 
investigated. 
Figure 6.5 
318K ~ ' 1 ~ ~ ~ ; I ~ i ~ ~ I I # I ; ~ ~ ~ ~ ~ ' ; t i l M ~ ' ~ , * , ~ ~ ~ l , M : j j
. , . , I x2 
14.0 12.0 p.p.m. 
Temperature dependence of the line widths of the two low field proton 
resonances observed in the IH-n.m.r. spectrum ofP(l-20). 
Changes in the line width of the low field resonances of P(1-20) as a function 
of temperature over the range 293-318K are presented in Table 6.5. For exchangeable 
protons it is nonnally observed that at low temperature the line width is detennined by 
the overall tumbling rate of the molecule under investigation, while at higher 
temperatures the exchange contribution is more important (Bevan et aI, 1985). These 
two contributions have opposite temperature dependencies. The exchange dominated 
region of the temperature dependence is clearly observed in Figure 6.5. However since 
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dmso freezes at 291 K, it is not possible to lower the temperature sufficiently to reach 
the region where the line width is dominated by the tumbling rate of the peptide. 
These data can be analysed quantitatively if it is assumed that the exchange rate shows 
Arrhenius behaviour as a function of temperature. The dynamics of the exchange 
process and the corresponding energies of activation have been calculated using such 
an analysis and are presented in Table 6.6. 
Table 6.5 
Table 6.6 
Temperature dependence of the line width of the low field resonances 
ofP(I-20}. 
Temperature (K) Line width (Hz) 
12.42ppm signal 14.03ppm signal 
298 160 114 
303 212 180 
308 320 274 
318 470 430 
Exchange parameters for the low field proton resonances ofP(I-20}. 
Chemical Shift (ppm) Exchange Rate (s-l) Activation Energy 
(303K) 
12.42 
14.03 
(303K) 
713 
562 
(kJ/mol) 
54.0 
60.5 
The exchange rates and activation energies of each of the low field resonances 
in P(1-20} are consistent with the presence of a proton involved in an ionic-type 
interaction. The observation of two resonances with similar populations and dynamics 
suggests that if this signal arises as a result of a salt bridge between the carboxylate 
side chain of Asp2 and the guanidinium group of Arg4, then it can exist in two 
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confonnations. A singJe low field resonance with similar dynamic properties has been 
observed in P( 1-11) indicating that in this peptide only one confonnation is present 
(Scanlon el al. 1992). 
Figure 6.6 
;..-
-
8 (a) 
r. 7 
-
3.1 
8 (h) 
7 
-~ ~
-::: 6 
3.2 3.3 3 .4 
I () 3 x I/T(K) 
5 + - - ~ - , - - - . - - - - - , - - - . . . - - , ,
3.1 3.2 3.3 3.4 
1().3 x I/T(K) 
Temperature dependence of the line width of the low field resonances 
of P(1-20) presented as an Arrhenius plot [In (?rLlW) vs. liT]. (a) 
shows the temperature dependence of the signal which resonates at 
14.03ppm at 303K. and (b) the 12.94ppm signal. The points are 
experimental data. the error bars indicating the estimated uncertainty in 
the line width (=:'Hz). The lines were calculated for exchange 
processes having the parameters described in Table 6.6. 
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6.4 Discussion 
The presence of strong daN connections in ROESY spectra along the entire 
backbone of P(I -20) indicates that much of the peptide exists in extended or random 
coil conformations. However, it is possible that minor populations of stable 
conformers are present. Sequential amide to amide through space connections in 
ROESY experiments can provide indications of preferred structures in the 
conformational ensemble sampled by the peptide. However, in cases where more than 
one through space connection is cited as evidence of a particular conformation, great 
care has to be taken that the observed connections arise from the same conformer. 
The observation of through space connections between the amide protons of Asp2_ 
Thr3 and Thr3-Arg4 is consistent with the presence of a type I P-tum about the 
residues Pro-Asp-Thr-Arg. Classically, such a tum would be stabilised by a hydrogen 
bond between the amide proton of the Arg residue the carbonyl oxygen of the Pro. If 
the Arg amide proton were freely accessible to solvent, its temperature coefficient 
would be expected to have a value of around 6.0 ppblK. The observation of a 
significantly lower temperature coefficient for this proton indicates that it is protected 
from solvent in some way, and is likely to be involved in a hydrogen bond. This 
strongly suggests that the sequential amide to amide connections observed between 
Asp-Thr-Arg do arise from a single conformation of the peptide and that a type I P-
tum is indeed present about the residues ProLAsp2-Thr3-Arg4. Although a low value 
of the 3 JHNa coupling constant is sometimes observed for the residue at position 2 of 
a type I P-tum, the observed value for the Asp residue in P(l-20) is typical of an 
extended conformation in the peptide. However it must be stressed that the n.m.f. data 
represents a time weighted average of all the conformations sampled by the peptide. 
The ROESY data indicates that much of the peptide exists in random coil 
conformation and the p-tum represents only a minor conformation. It is therefore not 
surprising that the Asp 3 JHNa coupling constant has a value which reflects the major 
population in the conformational ensemble of the peptide. 
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ai, 1988a ~ ~ Tendler, 1990). Indeed it has recently been suggested that the 
immunogenicity of peptides may be directly related to their propensity to form ordered 
structures in solution (Dyson. 1992). The identified structure in P( 1-20) directly 
overlaps the epitopes of a number of anti-MUC 1 monoclonal antibodies. suggesting 
that the salt-bridge locked type-I (j-tum may be present on the surface of the intact 
MUCI molecule where it has a role in the immune recognition of the mucin. 
Although the salt bridge locked type I (j-tum provides an attractive model for 
the interaction of MUC 1 related peptides with antibodies subsequent data have shown 
that even if this structural featureis present, it is not an absolute requirement for 
recognition of the peptides. 
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6.1 Introduction 
Peptides based on the tandem repeat sequence of the MUC 1 protein core 
compete for the same binding site on the monoclonal antibody C595 as the intact 
mucin (Section 5.2). Consequently studies of the conformation of the peptides in 
solution may provide a model for investigating the recognition phenomena associated 
with the interaction of MUC 1 with specific monoclonal antibodies. Previous studies 
on an eleven amino acid fragment of the tandem repeat sequence P(1-II) (Table 4.2) 
have revealed the presence of a type-I l3-tum in the peptide between the residues Pro1 
and Arg4 (Tendler, 1990). This tum overlaps the identified epitopes of several of the 
anti-MUC 1 antibodies and may be involved in antigen recognition and binding. 
In order to characterise further the solution structure of MUC 1 related 
peptides, high field n.m.r. studies have been performed on the twenty amino acid 
peptide P(1-20) (Table 4.2) corresponding to the entire tandem repeat sequence. It 
has been found that antibody binding sites tend to contain a relatively high proportion 
of aromatic residues (Section 1.7). Therefore it is likely that the peptides, when 
docking into the binding site of C595 enter a more hydrophobic environment than that 
found in aqueous solution. The n.m.r. studies ofP(I-20) were undertaken in ~ - d m s o o
both because this solvent facilitates the acquisition of good quality n.m.r. data, and as 
it was believed to resemble more accurately the environment of the peptides at the 
surface of the antibody. 
6.2 Sequence Specific Assignments 
The first stage in the assignment of the proton resonances in the n.m.r. 
spectrum of P( 1-20) to specific amino acid protons is the identification of the different 
spin systems present in the peptide. Spin systems were assigned on the basis of 
chemical shift and connectivity in one-dimensional and two-dimensional COSY and 
HOHAHA experiments using the methods described in Section 3.3. The amide to 
aliphatic region of a HOHAHA experiment is shown in Figure 6.1. Due to the 
presence of several residues of the same type in the peptide it was not possible to 
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Figure 6.1 Amide to aliphatic region of the IH HOHAHA spectrum ofP(I-20) in 
d6-dmso. The spectrum was recorded at 303K on a 400MHz 
spectrometer with a mixing time of 80ms. The capital letters are the 
amino acids given in the one-letter notation and the numbers refer to 
the position of the residue in the sequence, 
specifically assign the resonances from the spin system data alone, Consequently, 
sequence specific assignments were based on the observation of nuclear Overhauser 
effects (NOEs) between the resonances of protons on adjacent residues, As a result of 
the tumbling rate of the peptide, no through space connections were observed in 
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Figure 6.2 Amide to aliphatic region of the IH ROESY spectrum ofP(I-20) in d6-
dmso. The capital letters are as defined in Figure 6.1. Annotation of 
cross peaks between the resonances of Pro LAsp- T h r - A r ~ ~ illustrates 
the assignment strategy. 
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2D NOESY spectra, therefore the assignments were made on the basis of data 
obtained in ROESY experiments. The amide to aliphatic region of a ROESY spectrum 
of P(1-20) is shown in Figure 6.2. The evidence for the specific assignments of the 
individual proton resonances. presented in Table 6.1. is summarised below. 
Prol was assigned on the basis of a cross peak from its CaM and C ~ ~ proton 
resonances to the NH proton resonance of Asp2. Pros was assigned on the basis of a 
cross peak between its C ~ H H resonances and the CaM resonance of Arg4. This 
assignment was confirmed by the presence of a cross peak between the CI3H proton 
resonances of Pros and the NH proton resonance of Ala6. Pro' was assigned on the 
basis of cross peaks from its C ~ H H proton resonance to the CaM proton resonance of 
Ala6 and from its CaR proton resonance to the NH proton resonance of GlyS. Pro l2 
was assigned on the basis of cross peaks between its C ~ H H proton resonances and the 
CaR proton resonance of Ala 11. Due to· the degenerate nature of the proline spin 
systems it was not possible to unambiguously assign the resonances of Pro 13 at 303K. 
However at 298K the resonances of Pro 13 could be distinguished from those of the 
other proline residues and was assigned on the basis of a cross peak between its CaH 
proton resonance and the NH proton resonance of Ala14. The four alanine spin 
systems in the peptide are non-degenerate. Ala6• Alall and Alal4 were assigned on 
the basis of through-space connections to proline residues as described above. These 
assignments were confirmed by the observation of daN connections from Thr I 0 to 
Alall and from Alal4 to His15. A second resonance position for the NH proton of 
Ala6 was identified from an exchange cross peak between these two resonances 
observed in the ROESY and HOHAHA spectra. Ala20 was assigned on the basis of 
cross peaks between its NH proton resonance and the CaR and NH proton resonances 
ofSer19. Thr3 and Thr lO were assigned on the basis of daN connections to their amide 
proton resonances from the CaR proton resonances of Asp2 and Ser9 respectively. 
These assignments were confirmed by the presence of cross peaks between the CaR 
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Table 6.1 Chemical shifts (ppm) ofthe assigned amino acid residues for P( 1-20) 
determined at 303K. 
Residue NH PH Others 
Pro· 8.43 4.18 2.25, 1.86 -yH 1.86 
oH 3.23, 3.18 
Asp2 8.85 4.71 2.79,2.55 
Thr3 7.70 4.19 3.96 -yH 1.03 
OH4.86 
Arg4 7.93 4.51 1.70, 1.53 -yH 1.53 
oH 3.10 
eNH 7.52, 7.13 
Pro5 4.33 2.00,1.75 -yH 1.83 
oH 3.65,3.50 
Ala6 8.07 4.48 1.17 
(min) 9.17 
Pro' 4.30 1.98, 1.77 -yH 1.83 
oH 3.63 
Gly8 8.16 3.75,3.70 
Ser9 7.77 4.31 3.59, 3.51 
Thr lO 7.72 4.]8 4.03 -yH 1.02 
OH 4.82 
AlaI I 7.84 4.50 1.17 
Pro I2 4.54 2.]1,1.73 -yH 1.89 
5H 3.67,3.44 
Pro l3• 4.46 2.14, 1.73 -yH 1.73 
oH 3.40 
Ala l4 8.04 4.15 1.17 
His l5 7.94 4.46 3.05,2.95 2H 6.58 
4H 7.14 
GlyI6 8.18 3.89,3.73 
Val17 8.03 4.28 2.20 -yH 0.86 
Thr18 7.83 4.33 3.98 -yH 1.04 
Ser19 7.78 4.38 3.63,3.56 OH 5.05 
Ala20 8.06 4.19 1.25 
• Assignments determined at 298K 
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and C(jH proton resonances of Thr3 to the NH proton resonance of Arg4 and from the 
Cali and CI3H proton resonances of Thr lO to the NH proton resonance of Ala ll . 
Thr18 was therefore assigned by a process of elimination. The two glycine residues 
were assigned on the basis of daN connections from their CaH proton resonances to 
the NH proton resonances of Ser9 and Val17 respectively. Similarly, the two serine 
residues were assigned on the basis of daN connections from their CaH proton 
resonances to the NH proton resonances of Thr lO and Ala20. The Aspl residue was 
assigned on the basis of connections observed from its amide proton resonance to the 
Cali proton resonance of Prol. The low field position of the Asp2 amide proton 
resonance is typical for the second residue in a linear peptide (Aumelas et ai, 1989) 
and is due to the electron withdrawing effect of the positively charged N-terminus. 
Arg4, His15 and Val17 were assigned on the basis of daN connections observed from 
their amide proton resonances to the CaR proton resonances of Thr3, Ala14 and Gly16 
respectively. The full assignments for P( 1-20) are presented in Table 6. 1. 
6.3 Structural Studies 
With a knowledge of the sequence specific assignments, it is possible to 
investigate a number of parameters in order to determine whether any structural 
features are present in the peptide. 
6.3.1 Amide Proton Temperature Coefficients 
The temperature coefficients of the amide protons ofP(1-20) were determined 
between 293K-313K. The variation of chemical shift with temperature was found to 
be linear for all of the amide protons (Figure 6.3), suggesting that no major 
conformational change takes place in the peptide over this temperature range. The 
amide proton temperature coefficients are presented in Table 6.2. 
The Asp2 amide proton has the lowest temperature coefficient in the peptide at 
2.6ppblK, indicating that this proton is shielded from solvent and is likely to participate 
in a well formed hydrogen bond. In addition the amide protons of Arg4, Ser9, His15 
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and Ser19, with temperature coefficients below 4.6 ppb/K appear to have restricted 
access to solvent and may also be involved in hydrogen bonding. 
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Variation of the chemical shifts of the amide proton resonances of P( 1-
20) in d6-dmso. Lines drawn on the Figure are computer generated fits 
of the data obtained by the least squares method. 
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Table 6.2 Temperature coefficients for the amide protons ofP(I-20). 
Residue AM AT (ppblK) 
Asp2 2.6 
Thr3 5.0 
Arg4 3.6 
Ala6 6.0 
GlyS 5.2 
Ser9 4.6 
Thr lO 5.0 
AlaI I 6.2 
Ala l4 6.2 
Hisl5 3.2 
GlyI6 5.0 
ValI7 6.0 
ThrlS 6.0 
Serl9 4.2 
Ala20 6.2 
6.3.2 Coupling Constants 
The 3JHNa coupling constants for P(l-20) are presented in Table 6.3. The 
coupling constants were measured either directly from the 1 D spectrum, or in cases 
where signal overlap made this impossible from a double quantum filtered COSY 
(DQFCOSY) experiment. 
The coupling constants provide no indication of any preferred structure in P( 1-
20). However, from the assignments of the resonances of protons in the peptide it is 
clear that more than one conformation is present - for example the amide proton of 
Ala6 resonates at two positions. So although the values of the 3 JHNa coupling 
constants are characteristic of a random coil peptide, this observation does not rule out 
the possibility of minor conformations of preferred structures in the peptide. 
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Table 6.3 3JHNa coupling constants (Hz) for P(1-20) in ~ - d m s o o at 303K. 
Residue JJBNa(Hz) 
Asp2 8 
Thr3 9 
Arg4 7 
Ala6 8 
Ser9 7 
ThrlO 7 
AlaI I 8 
Ala14 7 
Hisl5 8 
Val l7 10 
Thr l8 8 
Ser19 8 
Ala20 8 
6.3.4 Nuclear Overhauser Effects 
In addition to enabling the assignment of resonances to specific amino acid 
protons, through space connections observed in the 2D ROESY experiments provide 
information regarding the structure of the peptide in solution. A cross peak between 
two proton resonances in a linear peptide indicates the presence of a significant 
population of conformers in which those two protons are separated by <3.sA (Dyson 
et aI, 1988a, 1988b). The amide to amide region of a ROESY spectrum of P( 1-20) is 
shown in Figure 6.4. A summary of the dipolar connections observed in P(l-20) is 
presented in Table 6.4. 
The pattern of connectivity observed between the amide protons of Asp2-Thr3-
Arg4 is consistent with the presence of a type-I p·turn being present in P( 1-20) 
(Section 3.2.4). A similar tum has previously been identified in the peptide P(l-II) 
(Tendler, 1990). In addition, a computational study undertaken on the peptide Pro-
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Asp-Thr-Arg-Pro identified a type-I {3-turn about the residues Pro-Asp-Thr-Arg as the 
major low energy conformer (Scanlon et ai, 1992). 
Figure 6.4 
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The pattern of connectivity observed between the amide protons of GlyS-Ser9 
and ThrlO-Ala 11 may indicate further structure in this region. Secondary structure 
calculations on the tandem repeat sequence have previously predicted a tum about the 
residues GlyS-Ser9-ThrlO (price el ai, 1990a). However the distance constraints 
imposed by the observed NOEs are not sufficient to definitely characterise any 
particular structural feature. 
6.3.5 Ionic Stabilisation of the p-tum in P(I-20) 
The resonance line width in an n.m.r. spectrum is correlated with the value of 
the transverse relaxation time T 2. 
I1W = 112 TT2 
where 11 W is the half width of the resonance line at half height. 
The value of T 2 is characteristically affected by exchange processes taking 
place in the sample. Consequently, monitoring the effect of temperature on the 
resonance line width can provide thermodynamic information regarding dynamic 
processes in the molecule under investigation. 
In the spectrum ofP(I-20) at 303K there are two very low field resonances at 
12.42 and 14.03 ppm (Figure 6.5). As a result of the broadness of the resonance lines, 
no connections were observed to these signals in COSY and HOHAHA experiments, 
with the result that they could not be assigned to specific protons. However, the low 
field nature of these resonances suggests that they may arise from protons involved in 
an ionic interaction. Simulated annealing calculations using a modified Metropolis 
Monte-Carlo algorithm have indicated that in the peptide Pro-Asp-Thr-Arg-Pro the 
major low energy conformer is stabilised by a salt bridge between side chains of the 
Asp and Arg residues (Scanlon et ai, 1992). Furthermore it has been shown that in the 
n.m.r. spectrum of P(l-20) in which the guanidinyl group of the Arg residue was 
blocked, no low field signals were observed (Scanlon et ai, 1992). In order to 
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STRUCTURAL STUDIES OF MUCI CORE RELATED PEPTIDES 
Chapter 7 - Results 
7.1 Introduction 
HMFG 1 and HMFG2 are munne monoclonal antibodies raised against 
preparations of human milk fat globule membranes which define epitopes within the 
tandem repeat of the protein core of MUC 1 (Burchell et ai, 1989). The minimum 
sequence required for HMFGl binding is Pro-Asp-Thr-Arg, while HMFG2 defines the 
epitope Asp-Thr-Arg. The fine specificity of these antibodies has been investigated 
(Briggs et ai, 1991) by testing their ability to bind to a series of tetrameric peptides 
based on the sequence Pro-Asp-Thr-Arg, according to the replacement net strategy 
developed by Geysen et al (1987) (Section 2.6). These studies have revealed that 
certain amino acids within the tetramer may be replaced with little or no loss of binding 
while the presence of others is essential (Briggs et ai, 1991). HMFG2 has an absolute 
requirement for the Asp in this sequence. Replacement of this residue with any other 
amino acid leads to a loss of antibody binding activity. In the case of HMFGI, the 
replacement of Asp with its homologue Glu still allows sequence recognition to occur 
(Briggs et ai, 1991). For HMFGI, the Arg residue is essential for antibody binding. 
With HMFG2, however, the Arg residue may be replaced by a number of other amino 
acids including Phe, Tyr and Leu, and binding activity is maintained. Interestingly, for 
HMFG2, although sequence recognition still occurs when the Arg is replaced by Leu. 
substitution of Arg for De removes the binding capacity of the peptide (Briggs et al. 
1991). 
In an attempt to identify a structural basis for these observations, the 
conformations of a number of peptides have been investigated by high field n.m.r. 
spectroscopy (Table 7.1). A type-I (j-tum has previously been identified in the 
peptides P(l-II) (Tendler, 1990) and P(I-20) (Chapter 6) about the residues Pro-Asp-
Thr-Arg. This structural feature directly overlaps the epitopes of both HMFG 1 and 
HMFG2 and is thought to be important in recognition of these peptides by the 
antibodies. 
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Table 7.1 Sequences of peptides, based on the tandem repeat sequence of MUC 1, 
investigated by high field n.m.r. spectroscopy. 
Peptide Sequence 
D-peptide Alp D T R P A P G9 
E-peptide Alp E T R P A P G9 
I-peptide A P D T I P A P G9 
L-peptide Alp D T L P A P G9 
V-peptide VIT S A P D T R P A P G12 
Detection of l3-tums by n.m.r. spectroscopy traditionally relies on three types 
of evidence. Firstly, a hydrogen bond between the amide proton at position 4 in the 
tum and the carbonyl oxygen of the residue at position 1 can be detected by a lowered 
amide proton temperature coefficient for the residue at position 4. This hydrogen 
bond, however, is not an absolute requirement for tum formation (Zimmerman & 
Scheraga, 1977 ; Chou & Fasman, 1977). Secondly, characteristically short proton-
proton distances associated with the tum may be detected through the observation of 
NOEs. Thirdly, type-I and type-II turns may have low values of the 3JHNa coupling 
constant for the residue at position 2 of the tum (Section 3.2.3). In the previously 
studied MUC 1 core related peptides, the n.m.r. data indicated that a significant 
population of extended conformations were present. This was reflected in the 
observation of coupling constants characteristic of unstructured peptides. 
Consequently, evidence for l3-tum formation was based on information from the first 
two sources. 
These studies are directed towards ascertaining whether fine differences in the 
specificity of anti-MUC 1 antibodies can be understood at the molecular level in terms 
of preferred structures adopted by the peptides. 
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7.2 HMFGI-Binding Peptides 
7.2.1 Inhibition Assays 
The ability of the D- and E-peptides to block the binding of intact urinary 
mucin to the anti-milk-fat-globule-membrane antibody HMFGI was determined in a 
two-site radioimmunometric assay (Section 4.3 .2). The inhibition of binding is 
presented graphically in Figure 7.1. 
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Figure 7.1 Inhibition ofMOCI binding to HMFGI by synthetic peptides. 
Both D- and E-peptides showed significant inhibition of antigen binding. These 
results confirm that replacement of the Asp residue with Glu in the tandem repeat 
sequence of the MUC 1 core protein still allows recognition of the sequence by the 
antibody HMFG I. 
7.2.2 N.m.r. Studies 
In an attempt to identify any structural similarity between the D- and E-
peptides, they have been investigated by high field n.m.r. spectroscopy. These studies 
were undertaken with the peptides dissolved in d6-dmso. Assignment of the proton 
resonances in the two peptides was carried out using the methods previously described 
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in detail in Chapter 3 and Chapter 6. The full assignments for both peptides are 
presented in Table 7.2. 
Table 7.2a Resonance assignments for the D-peptide in ~ - d m s o o at 303K. 
Residue NH flH Othen 
AlaI 8.05 4.20 1.35 
Pr02 4.43 2.09, 1.86 'YH 1.98 
OH 3.65,3.49 
Asp3 8.31 4.58 2.73,2.48 
(min) 8.60 4.64 2.76,2.56 
Thf4 7.43 4.20 4.00 'YH 1.00 
OH4.78 
(min) 7.63 4.20 4.00 'YH 1.02 
OH4.84 
Arg5 7.94 4.48 1.69, 1.56 'YH 1.56 
oH 3.10 
Pro6 4.34 2.03, 1.82 'YH 1.82 
OH 3.66,3.53 
Ala7 8.03 4.48 1.20 
Pr08 4.31 2.03, 1.85 'YH 1.85 
oH 3.55 
Gly9 8.01 3.78,3.71 
(min) 8.30 3.71 
In both D- and E-peptides a number of residues resonate in two positions 
(Table 7.2). It is possible that the doubling of these proton resonances arises as a 
result of cis/trans isomerisation of one or more of the proline residues in the peptides. 
However, there is considerable signal overlap in the proline spin systems in both 
peptides, and no direct evidence for the presence of a cis proline conformation was 
observed. This suggests that both of these peptides exist in a number of distinct 
conformations. 
86 
Chapter 7 - Results 
Table 7.2b Resonance assignments for the E-peptide in ~ - d m s o o at 303K. 
Residue NH PH Otben 
Alai 8.06 4.16 1.33 
(min) 7.91 4.22 1.17 
Pro2 4.41 2.10, 1.82 ')'H 1.90 
oH 3.63,3.44 
Glu3 8.17 4.28 1.93, 1.73 ')'H 2.29 
(min) 8.44 4.35 1.93, 1.73 ')'H 2.29 
TJu-4 7.55 4.21 3.93 ')'H 1.00 
(min) 7.71 4.23 3.98 ')'H 1.02 
OH4.96 
Arg5 7.95 4.50 1.71, 1.54 ')'H 1.54 
oH 3.07 
eNH 7.43 
(min) 7.76 4.37 1.60, 1.46 ')'H 1.46 
oH 3.07 
eNH 7.49 
Pro6 4.34 2.10, 1.84 ')'H 1.90 
oH 3.63,3.51 
Ala7 8.04 4.45 1.20 
(min) 8.39 4.49 1.24 
Pro8 4.29 2.02, 1.82 ')'H 1.90 
oH 3.54 
Gly9 8.01 3.73 
(min) 8.33 3.71 
In the previously studies peptides P(l-11) and P(l-20), the amide proton of the Asp2 
residue has been found to resonate at a low field position (Tendler, 1990 ; Chapter 6). 
This has been explained as being due to electron withdrawing effect of the tenninaI 
ammonium group which causes deshielding of the second residue amide proton in 
linear peptides (Aumelas el ai, 1989). Interestingly, the amide proton of the Asp 
residue in its minor conformation in the D-peptide and that of the Glu residue in its 
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minor conformation in the E-peptide both resonate at unusually low field positions. 
Since the Asp/Glu is the third residue in the D-IE-peptides this cannot arise as a result 
of deshielding by the N-terminal ammonium group and may be indicative of structure 
in this region. In order to further investigate the structure of the peptides in solution, 
the solvent accessibility of the amide protons was determined. The amide proton 
temperature coefficients for both peptides are presented in Table 7.3. 
Table 7.3a Amide proton temperature coefficients for the D-peptide. 
Residue Temperature Coefficient 
(Ai/AT) ppb/K 
AlaI 4.0 
Asp3 (maj) 5.8 
(min) 3.5 
TJu4 (maj) 3.6 
(min) 2.8 
Arg5 4.7 
Ala7 6.6 
Gly9 (maj) 6.2 
~ m i n l l 6.5 
Table 7.3b Amide proton temperature coefficients for the E-peptide. 
Residue Temperature Coefficient 
( 4 ~ / 4 T ) ) ppb/K 
AlaI 4.5 
GIu3 (maj) 5.1 
(min) 3.5 
rhf4 (maj) 4.3 
(min) 5.6 
Arg5 5.4 
Ala7 6.2 
Gly9 (maj) 6.0 
~ m i n l l 6.4 
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As shown in Table 7.3, the least solvent accessible proton in the D-peptide is 
that of the Thr in the minor confonnation. In addition Asp(min), Thr(maj) and Arg 
appear to be protected from solvent. In the case of the E-peptide the amide proton 
temperature coefficients are generally higher, and apart from the Glu( min) and 
Thr(maj) resonances, there is no indication of the amide protons being involved in 
hydrogen bonding. 
Short distances between protons in {l-tums can be detected through NOEs. In 
the case of the D-peptide, no cross peaks were observed in conventional NOESY 
experiments, and consequently NOE data were obtained from ROESY spectra. For 
the E-peptide, however, cross peaks were obtained in NOESY spectra, indicating a 
fundamental difference in the tumbling rate of the two peptides. The amide to amide 
regions ofNOE spectra for both peptides are presented in Figure 7.2. 
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Figure 7.2a Amide to amide region of the 200ms mixing time IH ROESY spectrum 
of the D-peptide in d6-dmso recorded at 600MHz and 303K. 
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As shown in Figure 7.2a, strong amide to amide connections are observed for 
the D-peptide between the resonances of Asp(maj)-Thr(maj) and Thr(maj)-Arg. This 
observation in conjunction with the lowered temperature coefficient of the Arg amide 
proton resonance, suggests that a type-I IJ-turn is present in the D-peptide about the 
residues Pro-Asp-Thr-Arg. 
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Figure 7.2b Amide to amide region of the 600ms mixing time IH NOESY spectrum 
of the E-peptide in d6-dmso at 400MHz and 303K. 
In the E-peptide (Figure 7.2b) the pattern of through-space connectivity is 
qualitatively the same with cross peaks observed between the amide proton resonances 
ofGlu (maj) - Thr (maj) and Thr (maj) - Arg. However the intensity of the cross peaks 
is significantly lower, indicating that either the distance between the amide protons in 
the E-peptide is greater, or the tum is present at a lower population. The presence of a 
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less populated or less well formed turn would explain the high value of the Arg amide 
proton temperature coefficient which shows no indication of hydrogen bonding. 
7.1.3 Role of Ionic Intenctions in tbe Stabilisation of MUCI Core Related 
Peptides 
In the n.m.r. spectrum of the D-peptide there is a single low field resonance at 
12.46 ppm. Although this resonance bas not been assigned to a specific proton, it has 
been suggested that the presence of similar low field signals in peptides P( 1-20) 
(Figure 6.5) and P(l-II) (Scanlon et ai, 1992) may be diagnostic of a salt bridge 
between the side chains of the Asp and Arg residues. The lowest field signal in the 
n.m.r. spectrum of the E-peptide is that of the Arg NH proton in its minor 
conformation (Table 7.2). However the presence of the carboxylate group in the side 
chain of the Glu residue still allows the possibility of an ionic interaction between it and 
the Arg guanidinium group. 
In order to assess the contribution of ionic interactions to the stabilisation of 
the observed turns in the D- and E-peptides, the influence of carboxylic group 
deprotonation has been investigated. Samples were prepared in which the peptides 
were lyophilised from pH 2.0 prior to being dissolved in ~ - d m s o . . Under these 
conditions the carboxylic groups as well as the guanidino group of Arg and the N-
tenninus would have been protonated, thereby precluding the possibility of salt bridge 
formation. For the samples described in Section 7.2.2 and Chapter 6, the side chains 
of the Asp/Glu residues were in the carboxylate (COO-) state, while the Arg side chain 
and amino terminus were protonated. The resonance assignments for both peptides in 
the carboxylic (COOH) state are presented in Table 7.4. 
Differences in the chemical shift of proton resonances in both peptides in the 
carboxylic and carboxylate states suggest that the conformations adopted by the 
Peptides are sensitive to changes in pH. For the D-peptide carboxylic sample, the Asp 
reSidue was found to resonate in two positions, indicating the presence of more than 
one stable conformation. The amide proton of the Asp residue in its minor 
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confonnation was no longer found to resonate at the unusually low field position 
observed in the D-peptide in the carboxylate state. However, a low field resonance 
was still observed at 12.46 ppm, suggesting that this resonance is not indicative of salt 
bridge fonnation. The presence of a similar low field resonance in Asp-containing 
peptides irrelevant to the MUCI protein core sequence (G.M. Davies, unpublished 
results) suggests that this signal may arise from the carboxylic proton of the Asp 
residue. For the E-peptide in the protonated state, a single resonance position is 
observed for each proton in all of the amino acid residues. 
Table 7.4a Resonance assignments for the D-peptide in the carboxylic state. 
Residue NH aD flH Othen 
AlaI 8.12 4.17 1.21 
Pro2 4.42 2.17, 1.84 -yH 1.84 
c5H 3.68, 3.47 
Asp3 8.40 4.69 2.92,2.60 
(min) 8.41 4.60 2.74 
rtu4 7.46 4.20 3.98 -yH 1.00 
OH4.85 
Arg5 8.00 4.49 1.70, 1.53 -yH 1.53 
c5H 3.10 
Pro6 4.36 2.10, 1.88 -yH 1.88 
Mf 3.67 
Ala7 8.12 4.47 1.36 
Pro8 4.32 2.06, 1.88 -yH 1.88 
c5H 3.57 
Gly9 8.07 3.74 
Confonnational analysis of the two peptides has been carried out on the basis 
of amide proton solvent accessibility and through-space connectivity in nuclear 
Overhauser enhancement experiments. The amide proton temperature coefficients are 
presented in Table 7.5. 
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Table 7.4b Resonance assignments for the E-peptide in the carboxylic state. 
Residue NH aD IJH Others 
AlaI 8.10 4.15 l.37 
Pro2 4.44 2.11, 1.85 'YH 1.85 
oH 3.65, 3.47 
Glu3 8.25 4.30 l.92, 1.75 'YH 2.30 
'fhr4 7.60 4.21 3.96 'YH 1.01 
ArgS 7.97 4.51 1.71, 1.54 'YH 1.54 
oH 3.10 
eNH 7.43 
Pro6 4.35 2.03, 1.77 'YH 1.77 
oH 3.65,3.55 
Ala7 8.05 4.47 1.20 
Pro8 4.33 2.03, 1.85 'YH 1.85 
oH 3.58 
Gly9 8.05 3.71 
Table 7.5a Amide proton temperature coefficients for the D-peptide in the 
carboxylic state. 
Residue 
Asp3 (maj) 
(min) 
Thf4 
Arg5 
Ala7 
Gly9 
Amide proton temperature 
coefficient (AcYAT) ppb/K 
1.5 
2.0 
2.4 
5.1 
6.2 
6.5 
In the D-peptide the amide proton temperature coefficients of the Asp residue 
in both its major and minor conformations and that of the Thr residue are very low, 
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indicating that these amide protons are shielded from solvent, and likely to participate 
in hydrogen bonding. However, the temperature coefficient of the Arg amide proton is 
significantly higher when the D-peptide is in the carboxylic rather than carboxylate 
state. The temperature coefficients of the E-peptide are again generally higher, with 
the lowest values being observed for the Glu and Thr amide protons. 
Table 7.Sb Amide proton temperature coefficients for the E-peptide in the 
carboxylic state. 
Residue 
Glu3 
'f1u4 
Arg5 
Ala7 
Gly9 
Amide proton temperature 
coefficient (4&'4T) ppb/K 
4.8 
3.5 
5.3 
6.1 
5.8 
For both peptides in the carboxylic state, strong daN through space 
connections were observed along the entire backbone. However no sequential dNN 
through space connections were present in either case. 
The absence of dNN connections, in conjunction with the high values for the 
amide proton temperature coefficient of the Arg residue in both peptides suggests that 
the p-turn which is present in both peptides in the carboxylate state is no longer 
formed when the carboxylic groups are protonated. This observation implies that ionic 
interactions may be important in stabilising the tum. Previously it was thOUght that 
low field resonances observed in peptides P(I-II), P(I-20) and the D-peptide may be 
diagnostic of the formation of a salt bridge. Molecular modelling studies had identified 
such an interaction between the side chains of the Asp and Arg residues in the 
pentapeptide Pro-Asp-Thr-Arg-Pro (Scanlon et ai, 1992). Since this low field 
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Table 7.6 Assignments of the proton resonances for the V -peptide at 303K in d6-
dmso at 303K. 
Residue NH aD PH Othen 
Vall n.d. 3.83 2.13 -yH 0.98 
Tbr2 8.43 4.55 4.03 -yH 1.13 
OH 5.18 
Ser3 7.93 4.35 3.63 OH4.88 
A1a4 8.07 4.50 1.23 
(min) 8.45 4.55 1.30 
ProS 4.35 2.05, 1.90 -yH 1.90 
oH 3.62, 3.57 
Asp6 8.20 4.57 2.77,2.50 
(min) 8.61 4.63 2.77,2.50 
Thr7 7.38 4.23 4.03 -yH 1.05 
OH4.75 
ArgS 7.97 4.50 1. 73, 1.58 -yH 1.58 
oH 3.13 
eNH7.60 
Pro9 4.37 2.05,1.90 -yH 1.90 
oH 3.68, 3.57 
Ala lO 8.10 4.58 1.23 
Pro 11 4.36 2.05, 1.90 -yH 1.90 
oH 3.68, 3.57 
Gly12 8.05 3.75 
(min) 8.35 3.75 
n.d. = not determined 
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resonance is observed in the D-peptide in both the carboxylate state and in the 
carboxylic state. where no possibility for salt bridge formation exists. it cannot arise 
due to the presence of an ionic interaction in the peptide. 
Although the modelling studies indicated that the Asp carboxylate group was 
involved in a salt bridge with the Arg guanidinium group, the proximity of the Asp 
residue to the N-terminus. which was protonated in all the n.m.r. experiments 
described above, means that this cannot be ruled out as the positively charged partner 
in an ionic interaction. In order to clarifY which of these two groups is the more likely 
to be involved in the salt bridge. the V-peptide was prepared. In this peptide the N-
terminus was extended by three residues, thereby reducing the likelihood of salt bridge 
formation between the N-terminus and the Asp side chain carboxylate group. 
The conformation of the V -peptide in ~ - d m s o o was investigated using high 
field n.m.r. spectroscopy according to the methods described above. The full 
assignments for the V-peptide are presented in Table 7.6. 
Conformational analysis of the V -peptide has been carried out on the basis of 
amide proton temperature coefficients and through space connectivity in 2D NOESY 
experiments as described above. The amide proton temperature coefficients for the V-
peptide are presented in Table 7.7. 
The temperature coefficients indicate that with the exception of the Thr 7 
residue, there is little evidence of hydrogen bonding involving backbone amide protons 
in the V-peptide. 
The pattern of through space connectivity in the V-peptide (Figure 7.3) is 
similar to that observed for other mucin core related peptides. Strong daN connections 
are observed along the entire length of the peptide backbone indicating that much of 
the peptide exists in extended conformations. However, the pattern of dNN-
connectivity observed is somewhat different. As in previously studied peptides dNN-
connections are observed between Asp6(maj)-Thr7 and Thr7_ArgS. In addition further 
dNN through space connections are present between Ser3-Ala4 and 
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Ala4-Pr05o. A summary of the through space connections observed in the V-peptide is 
presented in Table 7.8 . 
Table 7.7 Amide proton temperature coefficients for the V-peptide in d6-dmso . 
Residue Amide proton 
temperature coefficient 
(04/01) ppb/K 
Thr2 5.3 
Ser3 5.4 
Ala4 7.0 
Asp6 5.9 
Thr7 1.8 
Arg8 5.6 
Ala 10 6.5 
Gly12 6.5 
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Figure 7.3 Amide to amide region of the 600ms mixing time IH NOESY spectrum 
of the V-peptide in d6-dmso recorded at 400MHz and 303K. 
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Table 7.8 Through space connections observed in the V -peptide. 
VTSAPDTRPAPG 
*In the case of the prolines connections were observed to the O-proton 
resonances. 
Without confirmatory evidence from other sources, the pattern of through 
space amide to amide connectivity is insufficient to unambiguously define J3-turn 
conformations in the peptide. Structural predictions on a 60 amino acid peptide 
corresponding to three copies of the tandem repeat found in the MUC 1 core protein 
have indicated that there is a high probability of J3-tum formation in the region Ala-
Pro-Asp-Thr-Arg (Price et ai, 1990). The pattern of through space connectivity 
observed between the amide protons in the V-peptide may indicate the presence of a 
mixed population of J3-tum conformations in this region. 
7.3 HMFG2 - Binding Peptides 
7.3.1 Introduction 
The exquisite specificity of the anti-MUC 1 antibodies is revealed by the fact 
that the antibody HMFG2 recognises and binds to the tetrapeptide Pro-Asp-Thr-Leu, 
while substitution of the Leu for De destroys the binding activity (Briggs et ai, 1991). 
Structural studies on the L- and I-peptides (Table 7.1) have been undertaken using 
high field n.m.r. spectroscopy in an attempt to explain the fine differences in antibody 
specificity at the molecular level. Furthermore, substitution of the Arg residue for 
LeuIIle removes the possibility of forming a salt bridge to the Asp side chain and 
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thereby addresses the question of to what extent such an interaction is prerequisite for 
tum fonnation. 
7.3.2 Sequence Specific Assignments 
The IH resonances of the L- and I-peptides were assigned on the basis of 
chemical shift and connectivity in ID and 2D n.m.r spectra using the methods 
described above. Sequence specific assignments were obtained from through space 
connections observed in 2D NOESY spectra. The full assignments for both peptides 
are presented in Table 7.9. 
Table 7.9. Chemical shifts (ppm) for the L-peptide in ~ - d m s o o at 303K. 
Residue NH aD flH Otben 
AlaI 7.99 4.48 1.18 
Pr02 4.43 2.09, 1.90 'YH 1.90 
oH 3.53 
Asp3 8.33 4.59 2.73,2.53 
(min) 8.56 4.68 2.78,2.60 
Tffi4 7.36 4.20 3.99 'YH 1.01 
(min) 7.60 4.20 3.99 'YH 1.01 
LeuS 7.83 4.53 1.43 'YH 1.64 
oHO.88 
Pr06 4.30 2.03, 1.88 'YH 1.88 
oH 3.63,3.50 
A1a7 8.08 4.16 1.34 
(min) 8.38 4.55 1.25 
ProS 4.30 2.03, 1.88 'YH 1.88 
oH 3.63,3.50 
Gly9 8.03 3.70 
As with previously studies MUC 1 core related peptides, a number of the 
residues in both the L- and I-peptide were found to resonate in two positions. 
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However, in the case of the I-peptide a minor conformation of the Pr02 spin system, 
presumably corresponding to the cis isomer, was observed. The Pr02(min) resonances 
Table 7.9b Chemical shifts (ppm) for the I-peptide in ~ - d m s o o at 303K. 
Residue NH aD Otben 
AlaI 7.96 4.50 1.19 
Pral 4.45 2.25, 1.81 'YH 2.05 
em 3.51 
(min) 4.54 2.18, 1.75 'YH 1.90 
em n.d. 
Asp3 8.30 4.60 2.76,2.60 
(min) 8.55 4.68 2.71,2.53 
TJu4 7.43 4.22 3.99 'YH 0.99 
(min) 7.64 4.23 4.00 'YH 0.99 
lieS 7.71 4.38 1.75 'YH 1.50, 1.08 
-yCH3 0.89 
~ H O . 8 0 0
(min) 7.53 4.28 1.63 'YH 1.40, 1.01 
-yCH3 0.8O 
em 0.80 
Pr06 4.33 1.99, 1.81 'YH 1.88 
em 3.75, 3.60 
A1a7 8.04 4.18 1.36 
(min) 8.39 4.48 1.28 
ProS 4.41 2.10, 1.88 'YH 2.06 
~ H H 3.68 
Gly9 8.01 3.76 
(min) 8.36 3.73 
of the I-peptide were assigned on the basis ofa through space connection from it CaH 
proton resonance to the NH proton resonance of Asp3(min). Assuming the Asp3(min) 
represents the proportion of peptide conformations containing a cis proline at position 
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2, and Asp3(maj) reflects the population of trails proline conformations. then on the 
basis of the relative intensity of the amide proton resonances of Asp(maj)/(min) the 
ratio of translcis conformations of Pro2 is approximately 9: 1. No evidence has been 
found for cis proline conformations in any of the other MUC 1 related peptides studied 
to date. 
In both L- and I-peptides there is a single low field resonance at 12.46 ppm, 
confirming that this resonance is not diagnostic of a salt bridge interaction involving 
the Arg guanidinium group. 
Structural information regarding the two peptides was obtained from 
calculation of amide proton temperature coefficients and through space connectivity in 
2D NOESY spectra. The amide proton temperature coefficients for both peptides are 
presented in Table 7.10. 
Table 7.10a Amide proton temperature coefficients for the L-peptide. 
Residue Tempenture Coefficient 
(AMAT) ppb/K 
AlaI 
Asp 3 (maj) 3.4 
(min) 5.7 
Thr4 (maj) 2.6 
(min) 4.5 
Leu5 4.8 
Ala7 (maj) 6.3 
(min) 7.0 
Gly9 7.1 
The temperature coefficients of the Asp(maj), Thr(maj), Thr(min) and Leu 
amide protons in the L-peptide are all below the value of 6.0 ppb/K. expected for 
solvent exposed amide protons. This suggests that they may be involved in hydrogen 
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bonding. In the I-peptide the amide protons of Asp(maj) and Thr(maj) also appear to 
be protected from solvent. 
Table 7.10b Amide proton temperature coefficients for the I-peptide. 
Residue Tempenture Coemcient 
(ANA T) ppb/K 
AlaI 
Asp 3 (maj) 3.7 
(min) 5.5 
1'hr4 (maj) 3.3 
(min) 5.0 
neS (maj) 5.8 
(min) 5.1 
A1a7 (maj) 5.1 
(min) 5.5 
Gly9 7.5 
Amide-to-amide connectivities observed for the two peptides are shown in 
Figure 7.4. The pattern of through-space connectivity observed between the amide 
protons of Asp(maj)-Thr(maj)-Leu in the L-peptide, in conjunction with the low value 
of the temperature coefficient of the Leu amide proton strongly suggests that a type-I 
R-turn exists in this peptide about the residues Pral-Asp-Thr-LeuS. In the I-peptide 
the pattern of connectivity between the amide protons of Asp(maj)-Thr(maj)-I1e(maj) 
is consistent with the presence ofa type-I R-tum, however the intensity of the amide to 
amide cross peaks in the 2D NOESY experiments is lower than those observed in the 
L-peptide. In addition, the temperature coefficient of the Ile(maj) amide proton 
indicates that it is freely accessible to solvent. Consequently if such a tum is present in 
the I-peptide then it is likely to represent a very much lower population than the tum 
observed in the L-peptide. 
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Fiun 7.48 Amide to amide region of the 600ms mixing time IH NOESY spectrum 
of the L-peptide recorded at 400MHz and 303K. 
Fiun 7.4b Amide to amide region of the 600ms mixing time 1 H NOESY spectrum 
of the I-peptide recorded at 400MHz and 303K. 
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7.4 Discussion 
Since the antibody HMFG 1 is capable of recognising peptides containing either 
Asp or GIll, it is likely that there is some structural similarity between the two peptides. 
The n.m.r. data suggests that the D-peptide adopts a type-I p-tum about the residues 
Pro-Asp-Thr-Arg, as previously observed in other MUCI core related peptides 
(Tendler, 1990; Scanlon et ai, 1992). The E-peptide also appears to adopt a tum-like 
confonnation, however, the data suggests that the tum is either present in a lower 
population or is in a more open conformation than that found in a classical type-I 13-
tum. 
Previous studies of MUC 1 core related peptides have indicated that salt bridge 
fonnation may be important in stabilising the observed structure (Scanlon et ai, 1992). 
In order to further investigate the role of ionic interactions in the stabilisation of these 
peptides, samples of the D- and E-peptides were prepared corresponding to the 
carboxylate and carboxylic states. Comparison of the results obtained for the two 
peptides in the different ionisation states clearly suggested that the conformations 
adopted are sensitive to changes in pH. It appears likely, therefore, that the observed 
P-turns are stabilised by a salt bridge involving the side chain carboxylate group of the 
Asp/Glu residues. 
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In an attempt to identify the more likely positively charged partner in such an 
interaction, the V-peptide was investigated. The conformation of the V-peptide in ~ ~
dmso was found to be significantly different to other MUC I-core related peptides. 
Although the n.m.r. data was insufficient to unequivocally describe any single element 
of secondary structure in the peptide, the observation of through space connections 
between the amide protons of Asp6_Thr7 and Thr7_ArgS, in conjunction with the fact 
that previously studied peptides containing the sequence Pro-Asp-Thr -Arg form a 
type-I p-tum in this region, suggests that the V-peptide may also be capable of 
adopting a similar structural feature. Non-linear averaging of the n.m.r. parameters 
may explain why amide to amide connections consistent with the presence of a type-I 
p-tum are observed, while the temperature coefficient of the Arg amide proton 
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indicates that it is freely accessible to solvent. In a type-I ~ - t u m m it would be expected 
that this amide proton would be involved in a hydrogen bond with the carbonyl oxygen 
of Pro resulting in a lower value of its temperature coefficient. The only amide proton 
in the V-peptide which is protected from solvent is that of the Thr7 residue. In 
previously studied MUC 1 core related peptides the threonine residue at this position in 
the tandem repeat sequence has been found to have a lowered amide proton 
temperature coefficient. On the basis of molecular modelling data (Scanlon et ai, 
1992) it has been suggested that the low value of the temperature coefficient arises due 
to the presence of an inter-residue hydrogen bond from this amide proton to the side 
chain carboxyl oxygen of the Asp. However, the value of the Thr7 amide proton 
temperature coefficient in the V-peptide is significantly lower than has been observed 
for any other peptide studied to date. This may suggest that this amide proton is 
further protected from solvent in some way. 
The data obtained for the V-peptide does not clarify the role of ionic 
interactions in the stabilisation of structural features observed in MUC I related 
peptides. It appears that the V-peptide may still form a low population of type-I ~ ~
turn about the residues Pro-Asp-Thr-Arg, although the n.m.r. evidence for such a 
conformation is not conclusive. This may suggest that in the previously studied MUC 1 
core related peptides an interaction between the negatively charged Asp side chain and 
the positively charged N-terminus stabilises the observed type-I ~ - t u m . . In the V-
peptide the distance between the Asp residue and the N-terminus is considerably 
larger, consequently a similar ionic interaction is less likely. The inability of the V-
peptide to form such an interaction may account for the less well defined structure in 
this region. However, molecular modelling studies suggested that the lowest energy 
conformation of the peptide Pro-Asp-Thr-Arg-Pro involved a type-I ~ - t u m m stabilised 
by an ionic interaction between the side chains of the Asp and Arg residues (Scanlon et 
ai, 1992). Since protonation of the Asp/Glu side chain carboxyl groups in the D-IE-
peptides removes the capacity of the peptide to form a ~ - t u m , , it is likely that ionic 
interactions play some part in stabilising the observed structure in these peptides. 
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Therefore, if the through space connections obseJVed between the amide protons of 
Asp-Thr-Arg in the V-peptide are indeed indicative of a low population of ~ - t u m m
about Pro-Asp-Thr-Arg, then it may be that a salt bridge involving the Asp and Arg 
residues has a role in the stabilisation of this structural element. 
Data obtained for the 1- and L-peptides indicate that in the case of the L-
peptide at least, an ionic interaction between the side chains of residues in the MUC 1 
core related peptides is not essential for ~ - t u m m formation. Surprisingly, the L- and 1-
peptides appear to adopt somewhat different conformations. The temperature 
coefficient of the Ile(maj) amide proton in the I-peptide suggests that if a ~ - t u m m is 
indeed present then it is a less well defined structural element than the turn observed in 
the L-peptide. 
The structural differences observed for the D-IE-peptides and the I-IL-peptides 
may account for the observed difference in the reactivity of anti-MUCI monoclonal 
antibodies towards these peptides. However the n.m.r. data provides little indication 
of what is the most likely conformation of the peptides when interacting with the 
antibody. In the antibody-peptide complexes it is likely that the majority of the 
interaction between the molecules arises due to shape complementarity of the peptide 
surface and the binding site. Elements of secondary structure such as ~ - t u m s s may be 
important in orienting the peptide in such a way that antibody binding is possible. 
However it is likely that the backbone atoms which form the tum will be masked by the 
side chains of residues in the peptide. Consequently, in order to identify a likely 
binding structure, it is necessary to characterise the conformations of side chain groups 
in the peptides. Due to the flexibility of linear peptides in solution it is not usually 
possible to do this from the n.m.r. data. Indeed, in the case of the MUCI core related 
peptides studied to date, it is generally the case that the vast majority through space 
connections involve only backbone protons. Therefore, in order to unambiguously 
assign the structural features of the peptides which are important for recognition by 
anti-MUC 1 antibodies it will be necessary to elucidate their conformations when bound 
in the complex. 
CHAPTER EIGHT 
TOWARDS INVESTIGATIONS OF THE BOUND 
CONFORMATIONS OF P(l-20) 
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8.1 Introduction 
A number of n.m.r. techniques are now available which enable the study of 
peptides and small proteins in complexes with antibody fragments (Section 1.9). The 
applicability of a particular method depends fundamentally on the rate at which the 
peptide antigen exchanges between the bound and free state. Consequently, in order 
to determine which is the most suitable technique, it is necessary to quantifY the affinity 
of the antibody for its antigen. In addition, due to the size constraints imposed by 
n.m.r. spectroscopy, it is advantageous to use the smallest easily obtainable fragment 
of the antibody which retains its binding activity, usually the Fab. Finally, since all of 
these techniques involve observation of the antigen in exchange between the bound and 
the free states, it is necessary to assign the proton resonances of the free peptide in the 
aqueous conditions used for the n.m.r. studies of the antibody-antigen complex. 
The following chapter describes the initial steps towards studies of the 
conformation of peptides based on the tandem repeat sequence of the MUC 1 protein 
core in complex with the anti-mucin antibody C595. 
8.2 Proteolytic Digestion of Antibody 
The monoclonal antibody C595 was digested on a column of immobilised 
papain (Section 4.3.4). The optimum digestion time was determined by removing 
aliquots of material from the column which were analysed by SDS-PAGE on 12.5% 
polyacrylamide gels. The optimum digestion time was taken to be the point at which 
whole antibody could no longer be detected on the gel using a sensitive silver stain 
(Figure 8. 1 ). 
The proteolytic digest was purified as described in Section 4.3.5 and Western 
blotted onto a nitro-cellulose membrane. Development of the membrane with sheep-
anti-mouse-kappa-Jight-chain antibodies revealed a band of molecular weight 50,000 to 
be present (Figure 8.2), which is consistent with the presence of the Fab fragment of 
the antibody. The yield of Fab in these studies was 10-12%. Shorter digestion times 
on the papain column produced lower yields ofFab. 
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Figure 8.1 
Figure 8.2 
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Time-course for the digestion of monoclonal antibody C595 on a 
column of immobilised papain. Lanes I and 8 contain molecular weight 
standards the sizes of which are marked in kDa. Lanes 2 to 7 contain 
the crude proteolytic digest removed from the column after incubation 
times of 0, I h, 2h, 4h, I8h and 24h respectively. 
1 2 3 
WholeAb 
Fab fragment 
Western blot of the papam digest of monoclonal antibody C595 
developed with sheep-anti-mouse-kappa-light-chain antibodies. Lane 1, 
whole C595 . Lane 2, purified Fab fragment of C595 . Lane 3, crude 
digest after 18 hours. 
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The Fab fragment was tested for its reactivity with MUCI in a radioisotopic 
antiglobulin assay. Table 8.1 shows the binding of whole C595, purified Fab fragments 
and cell free supernatant (P3NSO) to urinary mucin. 
Table 8.1 Binding of whole antibody, Fab fragments and P3NSO to urinary mucin 
assessed by radioisotopic antiglobulin assay. 
Sample 
Whole C595 antibody 
Fab fragments ofC595 
P3NSO 
CounWmin ± S.D. 
8346 ± 346 
1743 ± 98 
81 ±43 
The assay clearly demonstrates that the Fab retains its binding activity for the 
mucin. The lower absolute value of counts recorded with the Fab compared to the 
whole antibody reflects the fact that the binding to mucin was detected with 
radiolabelled F(ab'h fragments from a polyclonal rabbit-anti-mouse-immunoglobulins 
antiserum. It is generally accepted that, due to the absence of the Fc region in the Fab 
fragment, a greater number of antiglobulin antibodies can bind to a whole antibody 
molecule. 
8.3 Detennination of the Affinity Constant of the Fab Fragment 
The binding constant of the Fab for the peptide P(1-20) was detennined by 
measuring the capacity of the peptide to quench the fluorescence of the antibody 
fragment. Quenching experiments were performed at pH 7.0 and pH 3.5 in order to 
determine whether the Fab fragment retained its binding activity at lowered pH. At pH 
7.0 in aqueous solution, the exchange rate of the amide protons in linear peptides is 
such that they cannot usually be observed in n.m.r. experiments. Lowering the pH 
slows the exchange rate, thereby enabling resonances of amide protons to be observed. 
Since important structural information regarding the conformation of peptides relies on 
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the observation of amide proton resonances, it is advantageous to undertake n.m.r. 
experiments at low pH. Clearly, in studies of antibody-antigen complexes, this is only 
valid if the antibody retains its specificity for the peptide under these conditions. 
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Effect of peptide on the fluorescence of antibody Fab fragments . 
(a) Fab of anti-MUCI antibody C595 . (b) Fab of anti-CEA antibody 
365. 
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At pH 7.0, saturation of the Fab fragment ofC595 with a 40-fold molar excess 
of P(l-20) resulted in a 24% quenching of Fab fluorescence (Figure 8.3a). A similar 
molar excess of the peptide P(7-20) which does not contain the identified epitope for 
C595 caused no quenching of Fab fluore$cence. Similarly P(1-20) caused no 
quenching of the fluorescence of the Fab of an irrelevant anti-carcino-embryonic-
antigen (CEA) antibody 365 (Figure 8.3b). At pH 3.5, P(1-20) retained its ability to 
quench the fluorescence of the Fab (Figure 8.4), indicating that the Fab retains its 
specificity for the peptide under these conditions. 
1.1 
a:i 0.7 
c=:: 
S95Fab pHJ .5 
595Fab pH7.3 
0.6 -t-------,r------,------r--__ ---. 
o 100 200 
P(1-20) Concentration IJg/ml 
Figure 8.4 Effect of pH on the quenching ofFab fluorescence by P(1-20). 
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It is interesting that P(I-20) can quench the fluorescence of the C595 Fab to 
such a large extent. The fluorescence of proteins arises primarily as a result of the 
tryptophan residues they contain. As (PI-20) contains no chromaphoric group with an 
absorption overlapping the excitation or emission wavelengths of tryptophan, the 
quenching cannot occur as a result of fluorescent energy transfer. Furthermore, as the 
Fab fragments were present in sub-micromolar concentrations in these experiments, the 
inner filter effect would have been negligible. Therefore the most likely explanation for 
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the observed quenching is that the peptide interacts with the tryptophan residue(s) in 
the Fab. causing a significant change in their environment. This implies that 
Tryptophan must be involved either at or very close to the binding site of the antibody. 
The binding constant of the Fab fragment ofC595 for P(l-20) was determined 
from the fluorescence quenching data. The fractional occupancy of the binding sites at 
different concentrations was expressed as a proportion of the maximal quenching 
(Table 8.2). 
Table 8.2 Proportion of Fab binding sites occupied at different peptide 
concentrations. The concentration of Fab fragments used in these 
experiments was 3.0 x 10-7M. 
Peptide concentration Proportion of Binding Sites 
(I'M) Occupied 
pH 7.3 pH3.S 
0.000 0.00 0.00 
0.27 0.10 0.07 
0.53 0.15 0.10 
0.80 0.18 0.12 
1.06 0.25 0.18 
1.33 0.30 0.21 
1.60 0.35 0.25 
1.86 0.42 0.29 
2.13 0.51 0.32 
2.39 0.63 0.34 
2.66 0.73 0.38 
2.93 0.77 
3.19 0.81 
The binding constant was determined from this data by Scatchard analysis 
(Figure 8.5). The binding constant of the Fab fragment of C595 for P(1-20) was 
calculated to be 0.26 x 10-6 M-l at pH 7.3 and 0.13 x 10-6 M-l at pH 3.5. 
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Scatchard analysis of the binding of peptide P(1-20) to Fab fragments 
ofC595. 
8.4 N.m.r" Studies of P(1-20) in Aqueous Solution 
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The 1 H resonances of P(1-20) in 100mM deuteroacetate buffer at pH 4.4 were 
assigned on the basis of chemical shift and connectivity in 10 and 20 n.m.r. spectra 
using the methods described in Chapter 3. Due to the problems associated with 
suppression of the water signal in aqueous n.m.r. spectra experiments were performed 
in both 020 and 90% H20/! 0% O2°. Firstly the spin systems of the non-
exchangeable proton resonances were identified from COSY and HOHAHA spectra of 
the peptide in 0 20 . The aliphatic region of a HOHAHA spectrum of P(1-20) in 0 20 
buffer is shown in Figure 8.6. Amide proton resonances were assigned from NH-side 
chain connectivities in a HOHAHA spectrum performed in 90% H20l1 0% °2°. The 
amide-to-aliphatic region of a HOHAHA spectrum of P( 1-20) in 90% H20/lO% °20 
buffer is shown in Figure 8.7. Sequence specific assignments were based on through-
space connectivities observed in ROESY spectra in 90% H20l1 0% 0 20 . As was the 
case with P(1-20) in d6-dmso, no through space connections were observed in 2D 
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NOESY spectra of the peptide. The full assignments for P( 1-20) are presented in 
Table 8.3. 
A single major resonance position was identified for all of the protons in P( 1-
20) under these conditions. There was no indication of any of the proline residues 
adopting a cis conformation. Structural analysis of the peptide was undertaken using 
amide proton temperature coefficients and distance constraints from through space 
connectivities observed in the 2D ROESY spectra. The amide proton temperature 
coefficients for P(1-20) are presented in Table 8.4. 
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Figure 8.6 Aliphatic region of the 40ms mixing time I H HOHAHA spectrum of 
P( 1-20) in D20 recorded at 400MHz and 31 OK. 
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Figure 8.7 
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Amide to aliphatic regIOn of the 40ms mixing time I H HOHAHA 
spectrum of P(1-20) in 90%H20/10%D20 recorded at SOOMHz and 
310K. 
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Table 8.3 
Residue 
Pro I 
Aspl 
Thr3 
Arg' 
ProS 
Ala6 
Pro7 
GlyS 
Ser9 
Thr lO 
Alai I 
Prol2 
Pro l3 
Alal4 
HislS 
Gly l6 
Val l7 
ThrI8 
Ser19 
Ala20 
Chemical shifts (ppm) of the proton resonances of P(I-20) in 
deuteroacetate buffer pH 4.4 at 31OK. 
NH PH Othen 
n.d. 4.44 2.47,2.07 -yH 2.07 
oH 3.44 
8.73 4.76 2.79,2.65 
8.16 4.32 4.21 -yH 1.19 
8.23 4.65 1.85, 1.76 -yH 1.68 
oH 3.22 
eNH 7.27 
4.42 2.29, 1.88 -yH 2.04 
oH 3.82,3.62 
8.30 4.60 1.38 
4.43 2.32, 1.97 -yH 2.07 
oH 3.82,3.67 
8.41 3.98 
8.07 4.53 3.92,3.89 
8.09 4.37 4.24 -yH 1.20 
8.15 4.63 1.36 
4.71 2.35, 1.89 -yH 2.04 
oH 3.83,3.63 
4.39 2.26, 1.84 -yH 2.02 
oH 3.80, 3.63 
8.24 4.26 1.34 
8.33 4.75 3.32,3.21 
8.34 4.03,3.93 
8.02 4.25 2.13 -yH 0.95 
8.18 4.43 4.24 -yH 1.21 
8.19 4.48 3.86 
7.94 4.19 1.35 
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Table 8.4 Amide proton temperature coefficients for P(I-20) in deuteroacetate 
buffer pH 4.4. 
Residue Temperature Coefficient 
(AliA T) ppb/K 
Aspl 6.4 
Thr3 7.8 
Arg' 9.6 
Ala6 8.4 
GlyS 7.6 
Ser9 7.4 
ThrlO 7.3 
AlaI} 8.2 
AlaI4 8.3 
Hisl5 8.0 
Glyl6 7.0 
Vall7 5.7 
Thr18 7.5 
Serl9 8.1 
Ala20 7.6 
The temperature coefficients of all the amide protons in P(I-20) are relatively 
high and provide no evidence of hydrogen bonding in the peptide. Furthermore, the 
pattern of through space connectivity observed in the 20 ROESY experiments (Figure 
8.8) suggests that the peptide exists in random coil conformations. Strong daN 
connections are present along the entire backbone of the peptide while no dNN 
connectivities are observed. Taken in conjunction, these results suggest that under the 
conditions used in these n.m.r. experiments P(l-20) adopts no preferred structure in 
aqueous solution. 
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Figure 8.8 
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Amide to aliphatic regIOn of the 200ms mixing time IH ROESY 
spectrum of P(l-20) in 90%H20/1O%D20 recorded at 600MHz and 
310K. 
8.5 Discussion 
Binding data obtained in the radioisotopic antiglobulin assay (Section 8.2) 
reveals that the proteolytically obtained Fab fragment of monoclonal antibody C595 
retains its specificity for MUC I. Furthermore, since P( 1-20) quenches the native 
fluorescence of C595 Fab, it is clear that the antibody fragments are capable of 
recognising and binding to peptides containing the identified epitope for C595 . The 
fluorescence quenching data also provides information regarding the nature of the 
antibody binding site. The fact that P( 1-20) is capable of quenching the Fab 
fluorescence implies that tryptophan residue(s) are involved either at or very close to 
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the binding site of the antibody. In addition P( 1-20) retains its capacity to quench the 
fluorescence of C595 Fab at a pH of 3.5. At this lower pH it is likely that the side 
chain carboxyl groups of both antibody and peptide are protonated. The epitope 
defined by C595 antibody contains an arginine residue which. under the conditions 
used in the fluorescence experiments would have existed with its guanidinium group in 
the positively charged protonated state. If a charge-charge interaction between the 
antibody and antigen provided a major contribution to the binding energy, then it 
would be expected that lowering the pH would result in a marked reduction in the 
affinity of the F ab for the peptide. Since this is not the case, it appears unlikely that 
intermolecular ionic interactions have a major role in the recognition of P(l-20) by 
C595. 
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The value of the affinity constant of C595 Fab for P(l-20) suggests that the 
peptide is in fast exchange between bound and free states under the conditions used in 
the fluorescence experiments. The most suitable n.m.T. technique for the study of 
rapidly exchanging antibody-peptide complexes is that of 20-TRNOE spectroscopy 
(Section 1.9.2). This method provides information regarding the conformations of 
bound peptide antigens by detecting magnetisation transferred from bound antibody 
protons to bound peptide protons. As the peptide is in fast exchange between bound 
and free states, such transfer of magnetisation is detected in the form of cross peaks 
between the resonance position for the antibody proton and that of the corresponding 
peptide proton in the unbound state. Consequently, for interpretation of 20-TRNOE 
spectra it is necessary to have obtained resonance assignments for the free peptide 
under the same conditions used for the n.m.r. experiments on the antibody-peptide 
complex. Due to the advantages for conformational analysis of recording n.m.r. 
spectra of aqueous peptides at low pH, and in view of the fact that the C595 Fab 
fragment retains its specificity for P(I-20) at pH 3.5, it is proposed to undertake 20-
TRNOE experiments on the complex at lowered pH. The proton resonances of P( 1-
20) have been assigned in deuteroacetate buffer at pH 4.4. Under these conditions 
there is no indication of the peptide adopting stable conformations. However. the 
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fluorescence quenching experiments suggest that ionic interactions may not be a 
significant factor in the binding of C595 Fab to P(1-20). Therefore, it is likely that the 
peptide, when docking into the antibody binding site enters a less polar environment to 
that found in aqueous buffer. Consequently it would not be surprising if the peptide 
were found to adopt a radically different conformation at the binding site of the 
complex to the random coil populations it adopts in deuteroacetate buffer. Given that 
P(1-20) has previously been shown to form stable conformations in ~ - d m s o , , the 2D-
TRNOE experiments may also be useful in addressing the question of the suitability of 
different solvents in investigations of the conformation of antigenic peptides. 
Due to the large size of the Fab it is often necessary to use extensive 
deuteration in order to resolve antibody proton resonances in the spectrum of the 
complex (Anglister et 01, 1988). In n.m.r. investigations of antibody-peptide 
complexes by 2D-TRNOE it is usual to perform several experiments using Fab 
fragments with different patterns of deuteration. Therefore it is necessary to have an 
efficient means for producing the Fabs. The yield ofC595 Fab obtained by proteolysis 
with papain is such that this is clearly an unsuitable means of producing Fab fragments 
for n.m.r. experiments. Furthermore from the SDS-P AGE gels of the antibody digest 
and Western blots of the Fab it appears that more than one species ofFab is produced 
by enzymatic proteolysis. Given the complexity of 2D-TRNOE spectra it is essential 
to have a single Fab species present in these experiments. Therefore before such 
studies can be undertaken it will be necessary to develop a more efficient means of 
producing the Fab fragment ofC595. 
CHAPTER NINE 
ANTIBODY SEQUENCING 
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9.1 Introduction 
Improvements in techniques for manipulation of DNA have made it possible to 
routinely express fragments of antibodies in bacterial cells (Reichmann et al. 1988). 
The production of recombinant Fv and Fab has a number of advantages over the 
alternative proteolytic methods for obtaining these fragments. Firstly, the recombinant 
fragments are highly homogeneous, which is essential if they are to be studied either by 
X-ray crystallography or n.m.r. spectroscopy. Secondly. if isotopic enrichment with 
n.m.r active nuclei is required, the high yield of antibody fragments obtained in this 
way is beneficial. The production of a DNA construct which codes for the binding 
domain facilitates acquisition of sequence data for the antibody. With a knowledge of 
the antibody sequence it is possible to develop computer models of the binding site. 
Furthennore, such a construct makes possible the generation of a panel of point 
mutated antibodies which may have differing specificities for the antigen. These 
techniques may be of fundamental importance in elucidating the processes of molecular 
recognition involved in antibody-antigen interactions. 
9.2 Amplification of C595 DNA 
The DNA coding for the light chain (<<) and the constant chain variable domain 
(VH) of antibody C595 was obtained by peR amplification as described in Section 
4.3.10. Figure 9.1 shows an agarose gel of the products of the PCR amplification. 
Negative controls for the peR reactions were included in the form of RNA extracts to 
which no reverse transcriptase was added prior to peR. 
As can be c1early observed from the gel. peR fragments of the correct 
molecular weight were obtained for both the V H -domain and the Ie-chain suggesting 
that the correct portion of DNA was amplified in both cases. 
9.3 Cloning of PCR Products 
The peR products were ligated into the PCR TM II vector and selected as white 
colonies on agar plates coated with X-Gal. Plasmid. prepared from overnight cultures 
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of transfonned E. Coli, was tested for incorporation of the appropriate peR fragment 
by restriction endonuclease digestion. Figure 9.2 shows the digests of plasmid into 
which had been incorporated either the VH -domain or the K-chain peR products. 
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Figure 9.1 Agarose gel (2%) of the Vwdomain and the K-chain PCR products for 
C595. Lane 1 contains the molecular weight standards, the sizes of 
which are quoted in base pairs. Lane 2 contains the negative control for 
K-chain PCR. Lane 3 contains the K-chain peR product. Lane 4 
contains the negative control for VH -domain peR. Lane 5 contains the 
V wdomain peR product. 
The agarose gels confinn that the DNA inserted into the vector was of the 
same size as the corresponding PCR product suggesting that the correct DNA 
fragment was inserted. 
9.4 DNA Sequencing 
Autoradiographs of sequencing gels for which the plasmid containing either the 
VH -domain or the K-chain peR products as inserts are shown in Figure 9 .3 . 
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Table 9.1 contains both the DNA and protein sequences for the Vwdomain and 
the VL-domain ofC595. The CDRs of both domains are underlined. 
(a) 
p l a . . q l m t ( I - I ~ . .
(b) 
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peR 
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Lane 
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Figure 9.2 Restriction digests of plasmid containing either (a) VH - or (b) K-chain 
DNA insert . In both cases, lane 1 contains the molecular weight 
standards, lane 2 contains the corresponding PCR product, and the 
remainder of the lanes contain digests of plasmid preparations. 
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(a) (b) 
GAT C GAT C 
Figure 9.3 Autoradiographs of the 2h DNA sequencing gels of the (a) Vii and 
(b) VL domains of antibody (595 . The gels have been labelled to 'how 
the sequence corresponding to (i) plasmid. (ii) cloning ite. (iii) primer 
and (iv) C595 antibody. 
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Table 9.1a DNA and protein sequences of the variable domain of the heavy chains 
of antibody C595. The DNA sequence is listed in the direction 5'-3', 
and the protein sequence from N- to C-tenninus. The CDRs in the 
protein sequence are underlined. 
Variable Heavy Chain (VH) DNA Sequence 
GTC CAG CTG CTG GAG TCT GGA OOA GGC 
CAG CCT OOA GOO TCC CTG AAA CTC TCC 
OCC TCT OOA TIC ACT TIC AGT AGe TAT 
TCT TOO GTI COC CAG ACT CCA GAC AAG 
GAG TIG GTC GCA ACC ATT AAT AGT AAT 
AOC ACC TAT TAT CCA GAC AGT GTG AAG 
TIC ACC ATC TCC AGA GAC AAT GCC AAG 
CTG TAC CTG CAA ATG AOC AGT CTG AAG 
GAC ACA OCC ATG TAT TAC TGT GeA AGA 
GAT GOT TAC GAC GAG GGA TIT GAC TAC 
CAA GOO ACC ACG GTC ACC GTC TCC TCA 
VH Protein Sequence 
VQLLESGGGLVQPGGSLKLSCAASGFTFSS 
YGMSWVRQTPDKRLELVATINSNGGSTYYP 
DSVKGRFTISRDNAKNTLYLQMSSLKSEDT 
AMYYCARDRDGYDEGFDYWGQGGTVTVSS 
9.S Identification of Similar Sequences 
TIA GTG 
TGT GeA 
GGe ATG 
AOO CTG 
OOT OOT 
GGe CGA 
AAC ACC 
TCT GAG 
GAT CGG 
TGG GGC 
The five protein sequences with greatest homology to the identified sequence 
for the VH -domain and the VL -domain ofC595 are listed in Table 9.2. 
124 
Chapter 9 - Results 125 
Table 9.tb DNA and protein sequences of the variable domain of the light chain of 
antibody C595. The DNA sequence is listed in the direction 5'-3', and 
the protein sequence from N- to C-terminus. The CDRs in the protein 
sequence are underlined. 
Variable Light Chain (V0 DNA Sequence 
AGT TCC GAG CTC GTT GTG ACG CAG GAA 
GCA ATC ATG TCT GCA TCT CCA GOG GAG 
ACC ATG ACC TGC AGT GCC AGC TCA AGT 
TAC ATC GAC TOO TAC CAC GAG AAG TCA 
TCC CCC AAA AGA TOO ATT TAT GAC ACA 
CTG OCT TCT OOA GTC CCT OCT CGe TTC 
AGT GOG TCT GOG ACC TCT TAC TCT CTC 
AGe AGC ATG GAG OCT GAA GAT OCT GeC 
TAC TGC CAG CAG TOO AGT AGT AAC CCA 
TTC GOA GOG GOG ACC AAG CTG GAA 
VL Protein Sequence 
SSELVVTQESPAIMSASPGEKVTMTCSASS 
SVSYIDWIHEKSATSPKRWIYDTSKLASGV 
PARFSGSGSGTSYSLTISSMEAEDAATYYC 
OOWSSNPPTFGGGTKLE 
TCT CCA 
AAG GTC 
GTA AGT 
GCG ACC 
TCC AAA 
AGT GGC 
ACA ATC 
ACT TAT 
CCC ACG 
Of fifty similar sequences identified by database searching all of the 
homologous sequences coded for immunoglobulin variable regions of the correct chain 
type. In the case of both the VH-domain and the VL -domain the most similar 
sequences were murine immunoglobulin. The majority of mismatches between the 
C595 and identified homologous sequences occurs within the CDRs. 
Furthermore, sequence data obtained for the CL -domain of C595 showed 100% 
homology with a number of other murine CL-domains (data not shown). Taken in 
conjunction these results suggest that the sequence data obtained for C595 is accurate. 
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Table 9.1 Sequences in the Swissprot database having the greatest homology to 
the identified protein sequence of (a) the C595 Vwdomain and (b) the 
C595 VL -domain. 
~ a l l
Protein Swissprot Percent Similarity 
AccessioD Number 
Mouse Ig heavy chain V-region HV53-M 90.7 
Mouse Ig heavy chain V-region HV55-M 89.7 
Mouse Ig heavy chain V-region HV54-M 88.7 
Mouse Ig heavy chain V-region HVl6-M 72.5 
Human Ig heavy chain V-region HV3G-H 66.9 
(b) 
Protein Swissprot Percent Similarity 
Accession Number 
Mouse Ig kappa chain V-region KV6F-M 83.8 
Mouse Ig kappa chain V-region KV6H-M 82.9 
Mouse Ig kappa chain V-region KV6I-M 82.9 
Mouse Ig kappa chain V-region KV6J-M 81.9 
Mouse IS kappa chain V - r ~ o n n KV6G-M 8l.9 
9.6 Discussion 
The fact that the detennined protein sequence of the variable domains of C595 
show such a high level of homology to other murine immunoglobulin sequences 
suggests that these data are indeed correct. The observed distribution of tryptophan 
residues both within and adjacent to the CDRs of C595 is interesting in the light of the 
ability of MUC 1 core related peptides to quench the fluorescence of its proteolytically 
generated Fab fragments. CDRJ of the light chain contains one tryptophan residue, 
and there is a further residue directly adjacent to CDR} of the light chain and CDRl 
and CDRJ of the heavy chain respectively. The fact that the peptides quench the 
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native F ab fluorescence suggests that the environment of one or more of these residues 
is significantly disturbed upon binding of the peptide. 
127 
CDR3 of the heavy chain contains six Asp/Glu amino acid residues which 
possess side chains which would be negatively charged at physiological pH. The 
minimum sequence required for C595 to bind to peptides based on the MUC 1 tandem 
repeat sequence is Arg-Pro-Ala-Pro (Section 5.2). Replacement net experiments based 
on the techniques of Geysen et al (1987) have identified that the arginine residue 
contained within the epitope is essential for antibody recognition of the peptides 
(Briggs et ai, 1992). These results may suggest that an ionic interaction between the 
positively charged side chain of the arginine residue of MUC 1 related peptides and the 
negatively charged heavy chain CDR3 plays an important role in antibody recognition. 
However, such a hypothesis is difficult to reconcile with the fact that the affinity of 
CS95 Fab fragments for peptide P(l-20) appears remarkably insensitive to pH. More 
data is required both on the conformation of the antibody combining site and the 
specific interactions involved in antibody-peptide binding before it will be possible to 
determine the important events in the processes of molecular recognition. 
CHAPTER TEN 
GENERAL DISCUSSION AND FUTURE WORK 
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The MUC 1 family of mucins are tumour associated antigens which can express 
epitopes that are relatively tumour specific. Although MUC 1 mucins are also 
expressed by normal tissues the profile of reactivity with anti-mucin antibodies 
indicates that there is a difference in the material derived from the two sources. It has 
been found that the major difference lies in the composition of the carbohydrate side 
chains and the extent of glycosylation, since the protein cores are identical. 
Interestingly, however, a number of the antibodies which show preferential tumour 
reactivity define epitopes within the protein core of the mucin. The explanation for 
this is thought to be that aberrant glycosylation of the protein core results in the 
exposure of epitopes which are masked in the normal mucin. Defining the precise 
conformational requirements for recognition of the mucin by different anti-MUC 1 
antibodies would provide an appreciation at the molecular level of the structural basis 
of the observed tumour specificity. 
Due to the size and complexity of the mucin molecules, attempts to define their 
structures in detail have been only partly successful. It has been found, however, that 
peptides based on the tandem repeat of the MUC 1 core protein compete for the same 
binding site on the antibodies as the intact mucin. Therefore these peptides provide a 
model for investigating the conformational requirements for binding to the antibodies. 
Structural studies on the twenty amino acid peptide P(l-20) based on the 
tandem repeat of the MUCI protein core utilising high field n.m.r. spectroscopy have 
indicated that in dimethyl sulphoxide a type-I {j-tum exists about the residues Pro l -
Asp-Thr-Ars-'. This element of secondary structure overlaps the epitopes of all of the 
anti-MUCI antibodies studied to date which recognise determinants within the protein 
core of the mucin. Simulated annealing calculations on this region of the peptide have 
identified that the lowest energy conformation consists of a type-I (j -tum Pro1-Asp-
Thr-Arg4 which is stabilised by an ionic interaction between the side chains of the Asp 
and Arg. This low energy conformation fits extremely well with the solution n.m.r. 
data observed for P( 1-20). Similar elements of structure have previously been 
identified as being important in antibody recognition of antigens. Therefore it appears 
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likely that this structural motif may be present on the surface of the intact MUC 1 
where it has a role in the immune recognition of the molecules by anti mucin 
antibodies. 
A number of studies have now been undertaken which attempt to characterise 
the fine specificity of several anti-MUC 1 antibodies by determining their reactivity with 
immobilised synthetic peptides. It has been shown that antibodies which define similar 
epitopes in the protein core of the mucin have very different profiles of reactivity with 
synthetic peptide analogues of the tandem repeat sequence. In an attempt to define a 
structural basis for these observations, a number of MUC l-core related peptides in 
dimethyl sulphoxide were investigated using high field n.m.r. spectroscopy. These 
studies revealed subtle differences in the conformations of the peptides. While the 
observed differences may account for the profile of reactivity of the peptides with 
different anti-MUCI antibodies, they provide little indication of the precise 
conformational requirements for binding. Consequently, initial experiments have been 
undertaken with the aim of characterising the bound conformations of the peptides. 
A number of n.m.r. techniques are available which allow investigation of the 
structure of small antigens in complexes with antibody. The suitability of a particular 
method depends crucially on the affinity of the antibody for the peptide. Fab fragments 
of the anti-mucin antibody CS9S have been obtained by proteolysis. These fragments 
have been shown to retain their specificity for both the intact mucin and the core 
related peptides. Furthermore, fluorescence quenching experiments have demonstrated 
that the interaction of these Fab fragments with P(l-20) involves at least one antibody 
tryptophan residue. and that it is unlikely that ionic interactions contribute significantly 
to the binding energy. The affinity of the fragments for the peptide P( 1-20) is such that 
the most suitable technique for investigating its bound conformation is 2D-TRNOE 
spectroscopy. However. as a result of the amount of Fab required by this method, 
enzymatic proteolysis is an unsuitable means of production of the antibody fragments. 
Consequently it is planned to produce recombinant Fab fragments of C59S. DNA 
coding for the variable domains of this antibody has been amplified and sequenced. 
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The obtained sequence confirms that a number of tryptophan residues are contained 
both within and adjacent to the CDRs. Interestingly, however, CDRJ of the heavy 
chain contains seven charged residues, six of which are acidic. This CDR is thought to 
be the most important for antibody recognition and binding. Since the defined epitope 
for C595 contains an arginine residue it is surprising that the affinity of the antibody is 
apparently insensitive to changes in pH. 
Studies of the MUC 1 related peptides in complex with antibody fragments 
should provide a clearer understanding of the precise conformational requirements for 
antibody binding. Work is currently underway in this laboratory to produce 
recombinant Fab fragments of C595. Initial results suggest that these recombinant 
Fabs retain their specificity for the mucin. This provides further conformation that the 
DNA sequence obtained for the antibody was indeed correct. This expression system 
should allow the production of large quantities of highly homogeneous Fab. It will 
also facilitate the incorporation of isotopic labels into the protein which would be 
required for investigation of this system by n.m.r. spectroscopy. With the availability 
of these Fab fragments it should be possible to determine the conformation of the 
MUCI core related peptides in complex with antibody. 
Knowledge of the sequence of the variable domains of the antibody enables the 
calculation models of the binding site. Modelling of the binding site of C595 is being 
undertaken at present. Such a model in conjunction with data on bound peptide 
conformations obtained from n.m.r. may provide insight into the conformational 
aspects of antibody recognition and binding. 
To further refine this model new peptides are being produced to which sugars 
are attached in O-linkage to the serine and threonine residues. These peptides will 
allow investigation of the effects of glycosylation both of the structure of the peptides 
and its effect on antibody binding. With this information it may be possible to define 
the epitopes which appear to be expressed only on the tumour derived material. Such 
studies are of fundamental interest to investigations both of the nature of MUC 1 
molecules and the processes of molecular recognition involved in antibody antigen 
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interactions. In addition they may allow the production of new anti-MUC 1 antibodies 
with improved specificity for the mucin which could be exploited in a clinical context. 
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